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Abstract 
 
During early Xenopus development, the neuroectoderm acquires regional identities along 
the anteroposterior axis and develop into brain, eye, and so on.  In this process, various 
region-specific transcription factors (TFs) have been shown to play roles in the 
specification and differentiation of these organs.  However, whether other TFs are 
involved in this process, how those TFs interact and regulate each other, and how TF 
activity is modulated by post-transcriptional modifications remain to be elucidated.  In 
this thesis, I addressed these three subjects by focusing on two uncharacterized zinc finger 
(Znf) genes and the homeobox gene otx2, which are expressed in the anterior 
neuroectoderm (ANE).   
In Chapter I, I investigated the roles of two uncharacterized Znf proteins, XXXX and 
YYYY, in eye formation, in concert with Otx2.  I chose XXXX and YYYY as candidate 
regulators of early eye development based on a systematic expression pattern database 
using a Xenopus ANE (ANE) cDNA library.  I first showed that both proteins were 
localized in the nucleus, suggesting their functions as TFs.  At the early neurula stage, 
xxxx and yyyy were expressed in the ectodermal sensory layer, and their expression 
domains were gradually restricted to the eye field and the neural fold as development 
proceeds.  Gain-of- and loss-of-function experiments using Xenopus embryos suggested 
that XXXX and YYYY are involved in eye development by regulating the expression of 
eye marker genes at the early neurula stage.  In addition, I found that XXXX and YYYY 
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physically interact with Otx2 as assayed by co-immunoprecipitation (Co-IP) analysis.  
Reporter analysis suggested that XXXX enhances the transrepression activity of Otx2 for 
posterior genes, whereas YYYY inhibits the transactivation activity of Otx2 for anterior 
genes.  These data suggest that XXXX and YYYY function as regulators of Otx2 in a 
distinct manner to execute eye development.   
In Chapter II, I investigated the role of modifications on Otx2, and demonstrated that 
both exogenous and endogenous Otx2 are phosphorylated at multiple sites in Xenopus 
embryos.  I identified three possible cyclin-dependent kinase (Cdk) sites and one 
possible Akt site, and analysed biological activities of phosphomimetic (4E) and non-
phosphorylatable mutants (4A) of Otx2 for those four sites.  In the neuroectoderm, the 
4E, but not the 4A mutant downregulated the Cdk inhibitor gene p27xic1, and promoted 
cell proliferation, possibly forming a positive feedback loop consisting of Cdk, Otx2, and 
p27xic1 for cell proliferation.  In addition, the 4A mutant downregulated the expression 
of the hindbrain marker gene gbx2 for anteroposterior patterning.  In contrast, the 4A 
mutant functioned as an activator on its own and upregulated the expression of eye marker 
genes, and later enlarged the eyes.  Consistent with these results, the interaction of Otx2 
with the corepressor Tle1 is suggested to be phosphorylation-dependent.  Finally, I 
found that XXXX enhances the repression activity by Otx2 through phosphorylation-
dependent interaction of Otx2 with XXXX.  These data suggest that the ternary complex 
of Otx2, XXXX and Tle1 is formed upon Otx2 phosphorylation for repressing target 
genes in the ANE.   
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Taken together, I propose a molecular mechanism in which transcriptional activator 
and repressor activities of Otx2 are regulated not only by its interaction with the 
corepressor Tle1 as well as the partner TFs XXXX and YYYY, but also by its 
phosphorylation states.  Thus, Otx2 could coordinate cell proliferation and 
differentiation during neural patterning and early eye development in Xenopus.   
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Abbreviations 
AD, activation domain 
ANE, anterior neuroectoderm 
BTB, bric-a-brac, tramtrack, broad-complex 
Cdks, cyclin dependent kinases 
ChIP, chromatin immunoprecipitation 
CNS, conserved non-coding sequence 
Co-IP, co-immunoprecipitation 
CRM, cis-regulatory module 
EFTFs, eye field specific transcription factors 
λPP, λ protein phosphatase 
MAPK, mitogen-activated protein kinase 
PH3, Phospho-Histone H3 
RPE, retinal pigment epithelium 
TFs, transcription factors 
NLS, nuclear localization signal 
WISH, whole mount in situ hybridization 
Znf, zinc finger 
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Gene names and gene symbols 
Official gene name (gene symbol): synonymous gene symbol  
goosecoid homeobox (gsc) gsc, Xgsc, goosecoid, gsc-a, gsc-b 
Meis homeobox 3 (meis3) XMeis3, mrg2, meis3-a, meis3-b 
orthodenticle homeobox 2 (otx2) Xotx2, otx-2, Xotx-2, otxA, otx2-a, otx-b 
cyclin-dependent kinase inhibitor xic1 
(cdknx) 
Xic-1, Xic1, p27XIC1, p28 
paired box 2 (pax2) XPax2, XPax-2, pax-2, pax2-a, pax2-b 
paired box 6 (pax6) XLPAX6, xpax6, pax-6, an2, mgda, wagr, pax6-a, 
pax6-b 
retina and anterior neural fold 
homeobox (rax) 
rx1, Xrx1, Xrax, Rx2A, rx, rx1a, rax-a, rax1, 
Xrx1A, rax-b, rx-1 
SIX homeobox 3 (six3) XSix3, hpe2, six3-1, six3-b 
SRY-box 2 (sox2) XLSOX-2, Sox-2, XSox2, Xsox-2, anop3, mcops3 
T-box 3 (tbx3 ) xtbx3, Xltbx3, tbx3-a, tbx3-b 
transducin like enhancer of split 1 (tle1) grg1, xgrg1, esg, esg1 
XXXX (xxxx)  
YYYY (yyyy) !
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General introduction 
 
Detailed molecular mechanisms in establishing the vertebrate basic body plan have been 
elucidated by analyses of various signaling molecules, intracellular signal transducers, 
and transcription factors (TFs) (De Robertis et al., 2000; Niehrs, 2004).  Among these 
factors, TFs directly regulate various genes that are involved in tissue-specific gene 
cascade or gene regulatory networks during development, so I have been interested in 
how TFs design outputs of gene expressions to drive a tissue-specific program in cellular 
and developmental regulatory processes.  Recently, comprehensive analyses such as 
RNA-seq and ChIP-seq provide the information about tissue-specific gene expression 
profiles and TF-binding genomic loci, but how TFs are coordinately regulated to exert 
their transcriptional activities by physical and functional interactions with other partner 
TFs and transcriptional cofactors (coactivators and corepressors) or by posttranslational 
modifications still needs to be elucidated by focusing on individual TFs.   
Xenopus laevis and X. tropicalis are useful model systems for molecular 
embryological studies, because large numbers of easily manipulated embryos can be 
obtained, and gain-of- and loss-of function analyses have been established.  Especially, 
using X. laevis embryos, many region- and tissue-specific TFs have been identified, such 
as the organizer genes, which are specifically expressed in the Spemann and Mangold 
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organizer (also called the gastrula organizer), including goosecoid (gsc), lim1 (the same 
as lhx1), and otx2, and the neural genes including otx2, rax, pax2, and gbx2.  From the 
extensive analyses of these TFs, we have learned about molecular mechanisms of early 
vertebrate development (Andoniadou and Martinez-Barbera, 2013; Lake and Kao, 2003; 
Yasuoka and Taira, 2018)  Compared to the study of the gastrula organizer and early 
neural patterning, it remains elusive how the early development of the brain and eye is 
regulated at the level of TFs.   
In this thesis, I focused on region- and tissue-specific TFs that are expressed during 
neural patterning and eye formation, and addressed two subjects; (i) analysis of two 
uncharacterized Znf genes, xxxx and yyyy isolated from the systematic expression pattern 
screening of an anterior neuroectoderm (ANE) cDNA library (Takahashi et al., 2005), (ii) 
analysis of the regulatory mechanism of transcriptional activities of the homeodomain TF 
Otx2 through posttranslational modifications in early development.   
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Chapter I 
 
Analysis(of(C2H2.type(zinc(finger(proteins,(XXXX(and(
YYYY,(for(eye(development(
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1.1 Introduction 
During early eye development in vertebrates, a part of the anterior neural plate is fated to 
the eye field that will form eye structures, such as eye vesicles including the retina and 
optic stalks at later stages.  Subsequently, sequential processes progress for eye 
formation: splitting the eye field, the formation of the optic vesicle and the optic cup, and 
lens induction (Graw, 2010; Zuber, 2010) (Fig. 1).  There are many reports for later eye 
development in vertebrate such as the specification of the optic vesicle and stalk, retina 
differentiation and lens placode formation.  However, the molecular mechanism to 
specify the eye field, which is one of the earliest event in eye development, is not fully 
understood, though a rough genetic cascade has been proposed (Zuber et al., 2003).   
The homeobox gene, otx2 is reportedly involved in early eye formation in Xenopus.  
In the neuroectoderm, otx2 starts to be expressed in the anterior domain which gives rise 
to the forebrain and midbrain, and plays an essential role in anteroposterior patterning by 
preventing Meis3 and Gbx2-mediated caudalization (Agoston and Schulte, 2009; 
Katahira et al., 2000) (Fig. 2A).  In early eye formation, Otx2 is involved in the 
specification of the eye field by upregulating an eye field-specific gene, rax, in the center 
of the otx2-expressing domain at the gastrula stage (Danno et al., 2008).  In turn, Rax 
downregulates otx2 to discriminate the eye field from the diencephalon (Zuber, 2010).  
Subsequently, eye field specific transcription factors (EFTFs) including pax6, which are 
essential for eye field specification, are expressed in the center of the region where otx2 
is expressed (Fig.2A,B).  In Xenopus, a gene cascade of TFs starting from otx2 and tbx3 
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through rax to pax6 is reported to define the eye field, and this region starts to express 
other downstream eye-specific genes, six3, lhx2, tll, and six6 (Zuber et al., 2003) (Fig. 
2C), suggesting that Otx2 functions at the top of the hierarchy in ocular morphogenesis.  
Although the genetic relationship of Otx2 with other EFTFs in the early eye gene cascade 
has been proposed, it remains elusive how individual TFs interact with each other to exert 
their functions in this cascade.   
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Chapter II 
 
Modulation(of(the(homeodomain(protein(Otx2(activity(in(cell(
proliferation,(anteroposterior(patterning(and(eye(formation(
by(phosphorylation(states(
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2.1 Introduction 
As described in Chapter I, I found several bands of Otx2 in western blotting (Fig. 10A,B), 
and Dr. Sudou, a previous member in our laboratory, also noticed that multiple bands of 
overexpressed Otx2 in Xenopus embryos migrate more slowly than an in vitro translated 
product, suggesting a post-translational modification of Otx2.  Similarly, a few previous 
studies using western blotting showed multiple bands of exogenous mouse Otx2 in 
transfected cultured cells (Mallamaci et al., 1996) and endogenous Otx2 in mouse 
embryos (Boyl et al., 2001), but post-translational modification of Otx2 has remained to 
be characterized.   
otx2 is required for the formation of the anterior portion of the head and eye 
development.  In early eye development, Otx2 upregulates an eye field-specific gene, 
rax, in the center of the otx2-expressing domain at the gastrula, and subsequently this 
region starts to express other downstream EFTFs including pax6 (Zuber, 2010).  In later 
eye development, otx2 restarts to be expressed in the developing optic vesicle (Martinez-
Morales et al., 2001; Viczian et al., 2003), and is involved in the specification of 
presumptive neural retina (pax6-positive cells) from the optic stalk (pax2-positive cells) 
in mice (Martinez-Morales et al., 2001) (Fig. 13).  After the retinal specification, otx2 
expression becomes restricted to postmitotic retinal progenitors, and determines bipolar 
cell fate (Brzezinski and Reh, 2015).  Thus, the knowledge of the role of Otx2 for head 
and eye formation is being accumulated.   
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Otx2 has both transactivation and transrepression activities for the regulation of 
downstream target genes.  Otx2 has a transactivation domain in the C-terminal region 
(Gammill and Sive, 2001), and directly upregulates a cement gland marker xcg1 in 
Xenopus (Gammill and Sive, 1997).  Otx2 also has a repression domain with a motif of 
SIWSPAS, which belongs to the engrailed homology region 1 (eh1) (Heimbucher et al., 
2007).  This domain is conserved in vertebrate Otx family proteins, and interacts with 
the corepressor TLE/Groucho (Heimbucher et al., 2007).  With this domain, Otx2 
functions as a repressor that inhibits the posterior gene gbx2 to form the midbrain-
hindbrain boundary (MHB) (Nakamura et al., 2005).  Furthermore, genome wide 
analysis of chromatin immunoprecipitation (ChIP) sequencing using X. tropicalis gastrula 
embryos has shown that Otx2 cooperates with the transcriptional activator Lim1/Lhx1 to 
bind specific cis-regulatory modules (CRMs) to activate anterior genes in the head 
organizer, whereas Otx2 cooperates with the repressor Goosecoid (Gsc) to inhibit non-
head organizer genes (Yasuoka et al., 2014).  Thus, both the transactivation and 
transrepression activities of Otx2 are important for regionalization and tissue patterning 
and function during embryogenesis.   
Recently, several reports have shown that Otx2 directly influences both cell 
proliferation and differentiation.  In mice, aberrant expression of Otx2 in the hindbrain 
induces the ectopic proliferation of neural progenitor cells (Wortham et al., 2012), and 
overexpression of Otx2 causes proliferation of dopaminergic progenitors in the ventral 
mesencephalon (Omodei et al., 2008; Vernay et al., 2005).  In addition, in a 
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medulloblastoma cell line, Otx2 upregulates cell cycle-positive regulator genes, such as 
cyclin D3, and downregulates cell cycle-negative regulator genes including p27 and 
differentiation-specific genes, such as neuroD (Bunt et al., 2012).  Thus, Otx2 is likely 
to be involved in both proliferation and differentiation.  However, the molecular 
mechanism of how Otx2 coordinates cell proliferation and differentiation remains 
unknown.   
Here, I show that Otx2 is phosphorylated, which confers transrepression activity, 
otherwise functioning as a transactivator on its own.  Functional analyses using 
phosphomimetic or non-phosphorylatable Otx2 mutants suggest that phosphorylated 
Otx2 represses the Cdk inhibitor gene p27xic1 and the posterior gene gbx2 for promoting 
cell proliferation and anteriorizing the neuroectoderm, respectively, whereas 
unphosphorylated Otx2 enhances the formation of the eye field and later the retina in the 
place of the optic stalk.  Additionally, I have shown that XXXX or Tle1 interacts with 
the phosphorylated mutant of Otx2 and potentiates the repression activity of Otx2.  
These functional and biological data suggest that phosphorylated Otx2 interacts with 
partner proteins including XXXX and Tle1 to form a repressive complex, leading to the 
downregulation of repressed target genes of Otx2, such as cell cycle inhibitor genes and 
posterior genes.  Thus, my data provide a new possibility that Otx2 exerts its versatile 
functions with cell proliferation- and differentiation-orientated activities through its post-
translational regulation.   
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2.2 Results 
 
Phosphorylation of exogenous Otx2 
Using western blotting analysis of N-terminally Myc-tagged full length (Myc-Otx2FL) 
and several deletion mutants of Otx2 constructed by previous members of our laboratory 
(Ms. Hosono, Mr. Minami, and Mr. Okada), we showed that modification mainly occurs 
in the region of amino acid positions 96-184 (Fig. 14A).  The amino acid sequence from 
position 96 to 184 indicated possible phosphorylation sites for Cdk (cyclin-dependent 
kinase; S*/T*-P or S*/T*-P-X-R/K; *, phosphorylatable residues), MAPK (mitogen-
activated kinase), casein kinase (S*/T*-X0-2-D/E/Sp1-3; Sp, primary phosphorylatable 
serine residue), and Akt kinase (R/K-X2-S*/T*) (Fig. 14B).  Notably, mouse Otx2 
reportedly possesses an Akt phosphorylation site at S115 (the corresponding site of 
Xenopus laevis Otx2 is T115; see Fig. 15), according to the database for the prediction of 
phosphorylation sites (see Materials and Methods).  I first took over this work from 
previous members, and tried to identify modification sites of Otx2 by the examination of 
four serine residues (S116, S132, S153, S158) and one threonine (T115) by introducing 
point mutations.  Because we found the suitable conditions in SDS-PAGE to separate 
the shifted bands of modified Otx2 by using Myc-Otx2ΔAD constructs, and that 
modification of Otx2 mainly occurs around the repression domain, we used Myc-
Otx2ΔAD constructs in the following experiments.  Replacement of a single serine with 
alanine revealed that S116A, S132A and S158A constructs eliminated the uppermost 
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band and increased the lower bands, compared with the wild type (WT), T115A and 
S153A construct (Fig. 14C).  Furthermore, a triple alanine mutant of Myc-Otx2ΔAD for 
S116, S132 and S158 (named ΔAD-3A) showed no slowly migrating bands (Fig. 14D; 
lane 3).  These data suggest that S116, S132 and S158, which have the S-P consensus 
motif for Cdk and MAPK, are responsible for multiple shifted bands (up to seven bands 
by combinations of three sites) of Myc-Otx2.  To examine this hypothesis, embryonic 
lysates expressing Myc-Otx2 constructs were treated with λ-protein phosphatase (λ-PP).  
As shown in Fig. 14D (upper panel), λ-PP treatment removed all of the modified bands 
of Myc-Otx2ΔAD (lanes 1, 2) and did not change the band of ΔAD-3A itself (lanes 3, 4), 
suggesting that slowly migrating bands of Myc-Otx2ΔAD were caused by 
phosphorylation at S116, S132 and S158.  The same experiment was performed with 
full-length Myc-Otx2 (FL), showing a similar result, in which all modified bands of Myc-
Otx2FL were removed by λ-PP treatment except for a weak shifted band (Fig. 14D, lower 
panel).  Consistently, Myc-Otx2FL-3A had only a single weak shifted band, and this 
band was not removed with λ-PP (Fig. 14D, lower panel; orange arrowheads), suggesting 
another distinct modification site around the activation domain.   
I next asked whether T115 of Xenopus Otx2 is an Akt phosphorylation site, although 
I did not detect a shifted band in Otx2 mutant 3A (ΔAD-3A) in western blotting (see Fig. 
14D, upper panel; lanes 3, 4).  In addition, there was no difference in band positions 
between ΔAD-3A (remaining T115) and ΔAD-4A (alanine mutation at T115 in addition 
to 3A) regardless of λ-PP (Fig. 14D, upper panel; lanes 3-6).  However, it was still 
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possible that phosphorylation at T115 may not have caused band shift in ΔAD-3A in 
western blotting, or may have been inhibited by alanine mutations at the three sites 
including S116 next to T115.  Therefore, I performed IP-western assays using anti-
Phospho-Akt Substrate antibody, which recognizes the R-X-X-Sp/Tp motif (Sp/Tp, 
phosphorylated residues).  Myc-Otx2ΔAD in embryonic lysates was 
immunoprecipitated with anti-Myc antibody and then was subjected to western blotting 
with anti-Phospho-Akt Substrate antibody.  The result showed that a band was detected 
with mutant ΔAD-3A but not with ΔAD-4A (Fig.14E, upper panel, lanes 2, 3), suggesting 
T115 as an Akt site.  Reasons why no clear band was detected in WT (lane 1) might be 
(i) phospho-Akt signals were dispersed in several shifted bands caused by 
phosphorylation at other sites, and (ii) phosphorylation at T115 was inhibited by 
phosphorylation at S116 or the other sites.  Thus, I identified four possible 
phosphorylation sites for Akt (T115) and Cdk/MAPK (S116, S132 and S158) in Otx2, 
and these sites are well conserved in vertebrate Otx2 as well as an Otx2 paralog, Otx5/Crx 
(Fig. 15).   
 
Phosphorylation of endogenous Otx2 
It is important to show whether endogenous Otx2 is phosphorylated, but no antibodies 
against phosphorylated sites of Otx2 are available.  As far as I know, there is no report 
on detecting phosphorylation of TFs expressed region-specifically and endogenously in 
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Xenopus embryos, like Otx2, as evidenced by band shift in western blotting, possibly due 
to their limited amounts in the whole embryo.  Therefore, I first estimated sensitivity of 
detection using a diluted series of otx2 mRNA injected into Xenopus embryos.  As 
shown in Fig. 16A, modified bands of full-length Otx2 without Myc-tag (Otx2FL) was 
clearly detected when otx2FL mRNAs were exogenously injected with greater than 200 
pg per embryo.  Based on an RNA-seq data from X. tropicalis (Owens et al., 2016), the 
amount of otx2 mRNA was estimated to be the order of 1 pg per embryo at the neurula 
stage.  I therefore predicted that endogenous Otx2 can be detected by western blotting 
with more than 200 X. tropicalis embryos.  As expected, I successfully detected multiple 
bands of the endogenous Otx2 protein immunoprecipitated from lysates of approximately 
800 X. laevis neurula embryos in total, and the upper bands were reduced by λ-PP 
treatment (Fig. 16B, left).  Similarly, shifted bands of exogenous Otx2FL were detected, 
and those were abolished by λ-PP treatment (Fig. 16B, right).  Thus, endogenous Otx2 
is actually phosphorylated, though the intensities of phosphorylated bands of endogenous 
Otx2 appeared to be lower than those of exogenous Otx2.   
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Phosphorylation of Otx2 depends on Cdk activity 
Because S116, S132 and S158 sites have the S-P motif (Fig. 14B), I speculated that 
MAPK or cyclin/Cdk complexes may phosphorylate Otx2.  To examine this, I tested the 
effect of MAPK on Otx2 modifications.  Overexpression of the constitutively active 
form of MAPKK, MAPKK* (Kosako et al., 1993), did not strongly affect the modified 
band patterns of Myc-Otx2ΔAD even with the high-dose injection of MAPKK* (Fig. 
17A).  In addition, Mr. Minami, a previous member, tested the blastocoel injection of a 
chemical inhibitor for MAPK, U0126, and reduced the activation form of MAPK, in the 
embryonic lysate, but this did not affect the modified band patterns of Myc-Otx2ΔAD 
(data not shown).  These data suggest that Otx2 does not respond to MAPKK and its 
downstream kinases. 
I next tried to hyperactivate endogenous Cdk activity in Xenopus embryos by 
overexpression of stable mutants of cyclin B1 (cyclin B1* for Cdk1) and cyclin A1 
(cyclin A1* for Cdk1 and Cdk2), both of which lack the destruction box (Geley et al., 
2001; Yamano et al., 2004).  Hyperactivation of Cdks by mRNA injection for HA-cyclin 
B1* or HA-cyclin A1* in the Xenopus embryo was verified by cell-cycle arrest of mRNA-
injected blastomeres (Fig. 17B, white asterisks).  Under these conditions, modifications 
of Myc-Otx2ΔAD were dramatically enhanced (Fig. 17C,D), and these modified bands 
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were almost removed by λ-PP treatment (Fig. 17C,D).  These data suggest that Cdk is 
involved in phosphorylation of Otx2.   
If Otx2 is phosphorylated by cyclin/Cdks, a preference of cyclin B/Cdk and cyclin 
A/Cdks for Otx2 phosphorylation might emerge.  To examine this, I constructed double 
alanine mutants (2A) for S116, S132 and S158 in ΔAD, in which only one site is 
responsible for Otx2 phosphorylation (Fig. 18A).  The intensity of uppermost bands of 
S132 (S116A/S158A) and S116 (S132A/S158A) constructs, but not that of S158 
(S116A/S132A), was increased by HA-cyclin B1* expression (Fig. 18B), whereas all 
modified bands were enhanced by HA-cyclin A1* expression (Fig, 18C), with an 
additional modified band (white arrowheads).  These data suggest that S116 and S132 
have a preference for both cyclin B/Cdk and cyclin A/Cdks, and that S158 has it for cyclin 
A/Cdks, if Otx2 is directly phosphorylated by cyclin/Cdks.   
To further examine Cdk-dependent phosphorylation of Otx2, I overexpressed the 
Cdk inhibitor p27xic1 in the embryo (Vernon, 2003).  I first verified cleavage arrest by 
p27xic1 mRNA injection (Fig. 19A left; white asterisks) as reported (Ohnuma et al., 
1999).  When a mixture of p27xic1 and Myc-Otx2ΔAD mRNAs were injected at the 2-
cell stage, modified bands of Myc-Otx2ΔAD were reduced, but a weak band still 
remained, which might be due to phosphorylation occurring prior to the accumulation of 
p27xic1 protein translated from injected mRNA (Fig. 19A, right; lanes 1, 2).  Therefore, 
I first injected p27xic1 mRNA alone at the 2-cell stage, then Myc-Otx2ΔAD mRNA was 
injected into the cleavage-arrested blastomeres at the 32-cell stage equivalent.  As 
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shown in Fig. 19A (right; lanes 3, 4), p27xic1 completely abolished modified bands of 
Myc-Otx2ΔAD, suggesting that phosphorylation of Otx2 depends on Cdk activity.  
These data also imply that the reduction of modified Otx2 by p27xic1 expression was 
probably not caused by dephosphorylation, because, once Otx2 was phosphorylated at 
the 2- to 32-cell stages (lane 2), it appeared to be stable until the late blastula stage when 
western blotting was performed (compare lanes 2 and 4).  Because phosphorylation of 
Otx2 appears to start very early, I examined developmental changes of phosphorylation 
levels using Myc-Otx2ΔAD (Fig. 19B).  The wild type (WT) and alanine mutants of a 
single serine at S132 (S132A) and S158 (S158A), and of 6 serines at S122, S123, S132, 
S153, S158, and S161 (6A) in Myc-Otx2ΔAD constructs were analyzed from stages 5 to 
10.5, as indicated.  Note that the 6A construct has S116, which is a phosphorylation site.  
The data showed that modification of Otx2ΔAD was already detected at the 16-cell stage 
(stage 5), gradually increased until the early gastrula stage (stage 10.5), and reached 
almost a plateau at stage 10.5 onwards (Fig. 19B).  In addition, mutation at S132 (S132A 
and 6A constructs) reduced phosphorylation levels compared to S158 mutation, 
indicating that S132 and S116 are more efficiently phosphorylated than S158 during 
cleavage stages.  Increase of phosphorylation levels until stage 9 correlates well with the 
cleavage cycle, supporting again the possibility that Otx2 is a substrate of cyclin/Cdks.   
Taken together, Otx2 has four possible phosphorylatable sites, and I referred to T115 
as A-site (putative Akt site) and S116, S132 and S158 as C-sites (putative Cdk sites) in 
the following experiments.   
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Otx2 mutants 4A and 4E have distinct functions in eye formation 
To ask whether known Otx2 activities are affected by phosphorylation states, I 
overexpressed phosphomimetic or non-phosphorylatable mutants and analysed eye 
phenotypes, which have been well-documented for Otx2 functions (Martinez-Morales et 
al., 2001; Nishihara et al., 2012).  A phosphomimetic mutant, Otx2-4E, was made by 
replacing A-site (T115) and three C-sites (S116, S132 and S158) with glutamate in 
Otx2FL.  Non-phosphorylatable mutants, named Otx2-T115A, -3A and -4A, were 
similarly made by replacing A-site, C-sites or all four sites with alanine, respectively.  
Each Otx2 construct was expressed unilaterally in the anterior neuroectoderm (ANE), 
which includes the eye field, and the phenotypes were scored at stages 38-42.  I 
categorized abnormal eye phenotypes into three types compared with the normal looking 
phenotype (Fig. 20A-D).  Expression of Otx2-WT, -4E -T115A, or -3A caused 
small/trace eye and ventral defect phenotypes in a dose-dependent manner (Fig. 20E), in 
which stronger phenotypes appeared to be obtained by expression of Otx2-WT, -4E, -3A, 
and -T115A in order.  By contrast, only Otx2-4A caused enlarged eye phenotypes, which 
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have not previously been reported by expressing any other Otx2 mutants in Xenopus 
(Andreazzoli et al., 1997; Isaacs et al., 1999).  Notably, either Otx2-T115A or -3A did 
not enlarge, but rather reduced eye sizes (Fig. 20E), indicating that mutations at both A-
site and C-sites are necessary for the activity of Otx2-4A.  Quantitative analysis for the 
area of the eye vesicle showed that the eye size in Otx2-4A expressing embryos was 
enlarged by approximately 1.3 times, whereas that in Otx2-4E expressing embryos was 
reduced by approximately 0.5 times, compared with control (Fig. 20F).  Section 
examination for the enlarged eye phenotype by Otx2-4A showed that the retinal tissue 
was expanded ventrally with the reduction of the retinal pigment epithelium (Fig. 20H,H’; 
arrowheads) compared with the control (Fig. 20G,G’).  These results clearly 
demonstrated that Otx2-4A has different activities in eye formation compared to the other 
mutants, and imply that exogenous Otx2-WT functions as phosphorylated forms, because 
WT exhibits similar activities to 4E (Fig. 20E).   
To further examine whether all C-site mutations are required for the activity of Otx2-
4A, I constructed triple alanine mutants of Otx2 (named A2A constructs), in which only 
one of C-sites (S116, S132 or S158) is intact, referred to as A2A-S116, -S132, or -S158, 
respectively.  As shown in Fig. 20I, A2A-S116 and A2A-S132 both caused small/trace 
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and ventral defect eye phenotypes.  By contrast, A2A-S158 caused enlarged eye 
phenotype in a dose dependent manner, though the fraction of enlarged eye phenotypes 
by A2A-S158 was lower than that of Otx2-4A.  This data indicates that mutations at 
T115, S116, and S132 are essential for enlarged eye phenotypes.   
I next examined the early effect of Otx2-4A and -4E by focusing on the eye field 
marker genes, rax and pax6.  Overexpression of Otx2-4A increased the expression of 
rax compared with the uninjected side (Fig. 21D), whereas Otx2-WT and -4E as well as 
the globin control did not affect (Fig. 21A-C).  The expansion of rax expression by 
Otx2-4A may be a reason for enlarged phenotypes.  Similarly, Otx2-4A enhanced the 
expression of pax6 compared with the uninjected side (Fig. 21H) and globin injected 
control (Fig. 21E), whereas Otx2-4E showed no effect (Fig. 21G).  The effect of Otx2-
WT on pax6 was complicated; Otx2-WT expanded pax6 expression but partially reduced 
it (Fig. 21F), possibly due to a combination of various phosphorylation states.  These 
data suggest the possibility that unphosphorylated Otx2, as mimicked by Otx2-4A, 
promotes eye field formation.  The enlarged eye phenotypes with aberrant ventral eye 
structures (see Fig. 20H,H’) raised another possibility that Otx2-4A converts the 
presumptive optic stalk to the retina.  Therefore, I examined the expression of pax2, six3 
and pax6 in the late neurula, in which pax2 is expressed in the optic stalk (OS) and MHB 
(Fig. 21I), whereas six3 is expressed in the optic vesicle (OV) and telencephalon (Te) 
(Fig. 21M), and pax6 is expressed in the OV and diencephalon (Di) side by side with 
different WISH intensities (Fig. 21Q).  Overexpression of Otx2-WT, -4E, and -4A all 
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inhibited pax2 expression in the OS (Fig. 21J-L), while Otx2-WT or -4E, but not -4A 
caused posterior shift of pax2 expression in the MHB (open arrowheads).  The reduction 
of pax2 in the OS by Otx2-WT, -4E, and -4A (Fig. 21J-L) are well consistent with the 
aberrant eye morphology at the tailbud stage on the ventral side where the OS is formed 
(see Fig. 20C,E).  Regarding six3 expression, Otx2-WT, -4E, and -4A expanded in the 
OV (Fig. 21N-P), and Otx2-4A appeared to be most effective for this expansion (Fig. 
21P).  As for pax6 expression, Otx2-WT, -4E, and -4A differently affected.  WT 
reduced OV but expanded Di pax6 expression (Fig. 21R,R’; black dashed lines, Di; white 
dashed lines, OV); and Otx2-4E slightly reduced the OV expression similar to WT (Fig. 
21S,S’), consistent with their small/trace eye phenotypes (see Fig. 20B,E).  Opposite to 
them, Otx2-4A expanded the OV pax6 expression (Fig. 21T,T’), consistent with its 
enlarged eye phenotypes (see Fig. 20D,E).  These data demonstrated that Otx2-4E and 
-4A have different activities in eye formation.  This raised the next question whether 
Otx2-4E and -4A have different activities in cell proliferation and anteroposterior 
patterning, which have been reported for Otx2 functions (Pilo et al., 2001; Acampora et 
al., 2000).   
 
Otx2-4E stimulates cell proliferation 
To investigate the effect of Otx2 on cell proliferation, Otx2-WT, -4E or -4A was 
expressed in the dorsoanterior region of the embryo, and then immunostaining was 
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performed with anti-PH3 (phospho-Histone H3) antibody as a mitosis marker.  The 
numbers of PH3-positive nuclei were counted in eGFP-positive and negative areas for 
quantitative analysis as shown in Fig. 22A-C.  The data showed that the ratio of the 
number of PH3-positive nuclei in injected versus uninjected areas was 1.27 ± 0.07 (mean 
± s.e.m.) and 1.38 ± 0.05 in Otx2-WT and -4E expressing embryos, respectively, whereas 
that was 0.727 ± 0.062 in Otx2-4A expressing embryos.  These ratios significantly 
differed from the control (0.944 ± 0.014) (Fig. 22D), suggesting that Otx2-WT and -4E 
both stimulate cell proliferation whereas Otx2-4A reduces it.  To confirm this, I counted 
the number of nuclei stained by DAPI (Fig. 22E-G).  Quantitative analysis showed that 
the ratio of cell number in injected versus uninjected areas was 1.08 ± 0.061 and 1.13 ± 
0.02 in Otx2-WT and -4E expressing embryos, respectively, whereas that was 0.894 ± 
0.019 in Otx2-4A expressing embryos.  The ratios in 4E and 4A embryos differed from 
the control (1.02 ± 0.04) (Fig. 22H).  Thus, these data suggest that Otx2-4E and -4A 
exhibited opposite effects on cell proliferation: Otx2-4E stimulates but -4A reduces 
proliferation.  
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To gain in vivo relevance of the Otx2 function in cell proliferation, I next performed 
loss-of-function experiments using antisense morpholino oligos (MOs) for otx2 and its 
paralog otx5.  Previous study using MO-injection in X. tropicalis embryos has shown 
that Otx2 and its paralogue Otx5, which are expressed in the ANE, have functional 
redundancy in head development (Yasuoka et al., 2014).  X. tropicalis is a diploid 
species closely related to the tetraploid species X. laevis and suitable for MO knockdown 
experiments, and all three C-sites of Otx2 are conserved in Otx5.  MOs together with 
FITC dextran as a tracer were injected into one blastomere at the 4-cell stage of X. 
tropicalis embryos; followed by PH3 immunostaining and DAPI staining at early neural 
stage.  The numbers of stained nuclei were counted and compared between injected and 
uninjected areas.  As shown in Fig. 23, the number of PH3-positive nuclei was almost 
unchanged in the ANE injected with standard control MO (A,A’,A”,C), whereas it 
significantly decreased in the region injected with otx2/otx5-MOs (B,B’,B”,C).  
Consistent with this, the number of nuclei decreased in the otx2/otx5-MOs injected area 
(Fig. 23E,E’,E”,F), but not affected in the control MO-injected area (Fig. 23D,D’,D’’,F).  
These data indicate that Otx2 and Otx5 are required for cell proliferation in the ANE, and 
this in vivo data is consistent with the enhancement of cell proliferation by exogenous 
Otx2-WT and -4E (see Fig. 22D,H).  This may also suggest that the reduction of cell 
proliferation by Otx2-4A is caused by dominant-negative action of Otx2-4A against 
endogenous phosphorylated Otx2 that stimulates cell proliferation, and the 
unphosphorylated form of Otx2 cannot take its place.   
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To ask how Otx2 stimulates proliferation, I focused on p27xic1 because Otx2 
reportedly inhibits the p27 gene (Bunt et al., 2012).  Analysis of our ChIP-seq data using 
X. tropicalis gastrula embryos (Yasuoka et al., 2014) showed co-occupancy of Otx2 and 
Tle1 to several potential CRMs near p27xic1 (Fig. 24A), suggesting that p27xic1 is a 
direct target gene of Otx2.  Using mRNA injection, Otx2-WT, -4E, or -4A with nβ-gal 
as a tracer was unilaterally expressed, and the expression of p27xic1 was examined by 
WISH.  Expression of Otx2-WT and -4E, but not -4A, downregulated p27xic1, 
compared with globin-injected negative control and on the uninjected side (Fig. 24B-E), 
consistent with the stimulation of cell proliferation by Otx2-4E (see Fig. 22D,H).   
To assess the gain-of- and loss-of-function data shown above, the expression 
domains of otx2 and p27xic1 and the distribution of PH3-positive cells in the early neurula 
were examined using sagittal hemisections.  The data showed that the otx2 expressing 
region did not overlap with that of p27xic1 (Fig. 24F,G), and has more mitotic cells than 
the posterior region (Fig. 24H), consistent with the involvement of otx2 in cell 
proliferation in the ANE.  These data suggest the existence of a positive feedback loop 
involving Otx2, Cdk, and p27xic in the regulation of cell proliferation (Fig. 24I).   
 
Activities of Otx2-4E and -4A for anteroposterior patterning 
In the neural plate, Otx2 is involved in anteroposterior patterning by directly inhibiting 
posterior genes, which are suggested to include gbx2 and meis2 (Yasuoka et al., 2014), 
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and by directly activating anterior genes such as xcg1 (Gammill and Sive, 1997) and rax 
(Danno et al., 2008).  I first examined gbx2 by ectopically expressing Otx2-WT, -4E or 
-4A, in the posterior neuroectoderm.  Both Otx2-WT and -4E downregulated the 
expression of gbx2 (Fig. 25B,C,C’; blue arrowheads) compared with the uninjected side 
and globin-injected control (Fig. 25A,A’).  This activity explains the posterior shift of 
pax2 expression in the MHB by Otx2-WT and -4E (see Fig. 21J,K).  Conversely, Otx2-
4A did not downregulate gbx2 expression (Fig. 25D,D’; white arrowheads), suggesting 
the possibility that only phosphorylated Otx2 has the ability to inhibit posteriorization. 
xcg1 is expressed in the cement gland, which is the anterior most organ (Fig. 25E).  
Ectopic expression of Otx2-WT, -4E and -4A all upregulated xcg1 (Fig. 25F,G,H; 
magenta arrowheads), and this activation was observed in the ventrolateral ectoderm, but 
not in the neuroectoderm as reported (Gammill and Sive, 1997).  To assess whether the 
ectopic upregulation of xcg1 by the Otx2 mutants requires their transactivation activity, I 
made transactivation domain-deleted constructs of 4E (ΔAD-4E) and 4A (ΔAD-4A).  
Neither ΔAD-4E nor ΔAD-4A upregulated xcg1 (Fig. 25I,J), indicating that the 
transactivation domain of Otx2-4E and -4A is required for their activation of xcg1.  
These data suggest that Otx2 has transactivation activity regardless of its phosphorylation 
states.   
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The above data suggest that the difference in function between Otx2-4E and -4A is 
repression activity.  To further examine whether phosphorylation states affect the 
repression and activation activity of Otx2, I performed luciferase reporter assays.  I first 
examined the response of the silencer of meis3, a posterior gene, which is expected to be 
repressed by Otx2.  The meis3-D2 silencer (Yasuoka et al., 2014) was inserted upstream 
of the SV40 promoter in the reporter construct, and this reporter alone showed a high 
level of luciferase activity in the animal pole region.  Under this condition, reporter 
activity was significantly repressed by Otx2-WT and -4E, but not by -4A (Fig. 25K).  I 
next tested combinatorial repressive activity of Otx2 with the interacting partner Gsc and 
the corepressor Tle1, which form the repression complex for negative target genes of 
Otx2 (Yasuoka et al., 2014).  Repression of the meis3-D2 reporter by Gsc and Tle1 was 
enhanced by co-expression of Otx2-WT, and this enhancement was also observed with 
Otx2-4A (Fig. 25L), suggesting that neither phosphorylation of Otx2 is required for nor 
unphosphorylated Otx2 interferes with the formation of a ternary repression complex.  
Because Otx2-4A and Tle1 did not repress the reporter (Fig. 25L), repression activity by 
a combination of Otx2-4A, Gsc, and Tle1 is probably due to recruitment of Tle1 to Gsc.  
Although Otx2-4A does not interfere with complex formation, Otx2-4A may weaken 
repression activity of the complex as implied in Fig. 25M (compare Otx2-4A with Otx2-
4E).   
I next examined an activated target gene of Otx2, rax, using the reporter gene SOP-
FLASH, which has 8 tandemly repeated rax enhancer elements binding for Otx2 and 
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Sox2 (Danno et al., 2008).  The data showed that both Otx2-4E and -4A exerted 
transactivation activity (Fig. 25N), similarly to activation of the xcg1 gene by Otx2-4E 
and -4A (see Fig. 25G,H).  Because Sox2 is expressed in the neuroectoderm (Mizuseki 
et al., 1998) and has a transactivation domain (Nowling et al., 2000), a combination of 
Sox2 and Otx2 may function as activator regardless of phosphorylation states of Otx2.  
Because Otx2-4E did not upregulate the endogenous rax gene (see Fig. 21C), activation 
of the rax reporter by Otx2-4E may be due to the “boosted CRM” by 8 tandem repeats.  
Taken together, it is suggested that phosphorylation of Otx2 is required for its repression 
activity, but does not affect transactivation activity itself.   
 
Otx2-4E, but not -4A interacts with Tle1  
To investigate how phosphorylated Otx2 functions as a gene repressor, I tested the 
association with other repressor factors.  The eh1 repression domain of Otx2 reportedly 
interacts with TLE/Groucho (Heimbucher et al., 2007).  Therefore, I tested the physical 
interaction between Otx2 mutants and HA-tagged Tle1 by Co-IP assays (Fig. 25O).  A 
co-immunoprecipitated band of HA-Tle1 was detected with Myc-Otx2-4E as well as 
Myc-Otx2-WT (magenta arrowheads), but barely with Myc-Otx2-4A, consistent with the 
data that neither Otx2-4A alone nor co-expression with Tle1 exerted repressive activity 
for meis3-D2 luciferase reporter (see Fig. 25K,L).  The reason why the intensity of the 
co-immunoprecipitated Tle1 band with WT was weaker than that of 4E (Fig. 25O) is 
possibly due to partial phosphorylation of WT.  These data suggest that phosphorylation 
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of Otx2 is required for the interaction with Tle1 to exert its own repression activity.  The 
phosphorylation-dependent interaction of eh1 domains with TLE has not previously been 
reported.   
 
Otx2-4E but not -4A interacts with XXXX  
Fig. 26I;
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2.3 Discussion 
 
Repressor activity of Otx2 conferred by post-translational modification 
In this study, I have shown that Otx2 exists in two distinct states, phosphorylated and 
unphosphorylated states.  Using phosphomimetic and non-phosphorylatable constructs 
of Otx2, I demonstrated that phosphorylated Otx2 can function as both repressor and 
activator, whereas non-phosphorylated Otx2 can function solely as an activator.  To date, 
only a few TFs have been reported to be converted between being an activator and a 
repressor by post-translational modification.  The SoxE group of TFs including Sox9 
are converted by SUMOylation from an activator to a repressor by displacing CBP/p300 
and recruiting Tle4/Grg4 (Lee et al., 2012).  Another case is Pax2, transactivation of 
which is enhanced through JNK kinase-mediated phosphorylation in the activation 
domain by blocking TLE/Groucho (Cai et al., 2003).  Thus, I have shown the third case, 
in which phosphorylation of Otx2 enables it to function as a repressor through the 
interaction with Tle1 and XXXX (Fig. 27), opposite to the case of Pax2.   
It is noted that Otx2 has a novel eh1 domain with a Cdk site (SIWSPASISP; 
underlined is a possible Cdk site), which is only present in the Otx family proteins (Otx1, 
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Otx2, and Otx5/Crx) as well as a few other TFs (Copley, 2005).  The eh1 domain is 
present in many metazoan TFs (Copley, 2005) and known to interact with TLE family 
proteins through the conserved C-terminal WD40 repeat domain (Heimbucher et al., 
2007; Pickles et al., 2002). Because some WD40 domains of ubiquitin ligases and 
phosphatases, such as β-Trcp and Cdc4, are known to interact with a phosphorylated 
serine residue in their substrates (Yaffe and Elia, 2001), it is possible that one of the 
WD40 repeats of TLE may interact with the eh1 domain with a phosphorylated site in 
Otx2.   
 
Role of cyclin/Cdk-dependent phosphorylation of TFs 
From my observations, I propose a positive-feedback-loop model for Otx2 functions in 
cell proliferation (Fig. 24I).  In this model, in a proliferative state, Otx2 is 
phosphorylated by elevated Cdk activity, and phosphorylated Otx2 becomes to repress 
p27xic1, which, in turn, derepresses cyclin/Cdk activity to enhance phosphorylation of 
Otx2, thereby forming a positive feedback loop (Fig. 24I, left).  When the cell cycle is 
arrested, cyclin/Cdk activity decreases and hence phosphorylated Otx2 decreases, causing 
derepression of p27 expression to repress Cdk, keeping unphosphorylation state of Otx2 
(Fig. 24I, right).  Thus, the phosphorylated and unphosphorylated states of Otx2 can be 
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toggled by the cell cycle.  However, it is not known how the phosphorylated state of 
Otx2 is changed to the unphosphorylated state.  There are two possibilities: (i) 
dephosphorylation of Otx2 by phosphatase, and (ii) degradation of phosphorylated Otx2.  
I did not observe any difference in instability of the Otx2-4E mutant compared to -4A by 
western blotting, which does not support the second possibility, and denies a 
phosphorylation dependent degradation.  A putative PEST sequence, an indicator of 
rapidly degraded protein, is present in the Xenopus Otx2 protein (Mori et al., 1994; 
Williams and Holland, 1998), and Otx2 may have a short half-life.  Therefore, 
unphosphorylated Otx2 could be generated through the rapid turn-over of Otx2 regardless 
of its phosphorylation state.   
I have shown that endogenous Otx2 is phosphorylated, but its phosphorylation levels 
were much lower than those of exogenous Otx2 (Fig. 16B).  This difference might be 
caused by the timing of protein production and the number of proliferating cells where 
phosphorylation of Otx2 supposedly occurs.  For exogenous Otx2, mRNA was injected 
into the animal pole region at 2- or 4-cell stages, and translated in the presumptive 
ectoderm from early cleavage stages, and the translation product is phosphorylated until 
the blastula stage (Fig. 19B) by Cdk1 activity, which oscillates with a period of ~30 
minutes  during the cleavage cycle (Hörmanseder et al., 2013).  By contrast, in the in 
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vivo situation, otx2 starts to be transcribed in the dorsal endoderm and mesoderm at the 
late blastula stage and in the dorsal ectoderm at the early gastrula stage (Sudou et al., 
2012), and then the endogenous Otx2 protein accumulates in the head organizer and the 
ANE, and the proliferation rates in these regions dramatically decrease especially in the 
head organizer (Fig. 24H).  Therefore, even if phosphorylation levels of endogenous 
Otx2 in proliferating cells are high, the average phosphorylation level of major non-
proliferating and minor proliferating cell populations in a gastrula or neurula embryo is 
much lower than those of exogenous Otx2.   
I have proposed a positive feedback loop involving Cdk-dependent phosphorylation 
of Otx2 for cell proliferation (Fig. 24I).  Similar feedback loops involving other TFs are 
also reported, but the regulatory mode is different from Otx2.  That is, TFs are switched 
“on” or “off” by Cdk-dependent phosphorylation to promote cell cycle progression.  An 
example for regulation by an “on” switch is FOXM1.  FOXM1 is activated by the 
phosphorylation of the N-terminal inhibitory domain by cyclin/Cdk to upregulate cyclin 
B and cdc25B, thereby forming a positive feedback loop for cell proliferation (Park et al., 
2008; Major et al., 2004).  An example for an “off” switch is FOXO.  FOXO 
upregulates the Cdk inhibitor genes p27kip1 and p21WAF1, but, upon phosphorylation 
by cyclin/Cdk, undergoes nuclear export, which virtually switches off the function of 
FOXO, leading to cell proliferation (Schuff et al., 2010; Liu et al., 2008; Stahl et al., 2002).  
In the case of Otx2, Cdk-dependent phosphorylation confers repressor activity to Otx2 
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for repressing p27xic, otherwise it functions as an activator on its own as mentioned above, 
differing from simple switch on or off regulations.   
Regarding tissue specification and differentiation, Cdk-dependent phosphorylation 
generally negatively regulates activity of TFs that directly activate differentiation genes.  
For example, the phosphorylation of the myogenic TF MyoD by cyclin/Cdk leads to its 
degradation to prevent muscle differentiation (Kitzmann et al., 1999).  During 
neurogenesis, the Cdk-dependent phosphorylation of Ngn2 (neurogenin 2) inhibits its 
neural differentiation activity (Ali et al., 2011; Hindley et al., 2012).  In these cases, 
Cdk-dependent phosphorylation of the TFs switches off their functions.  Taken together, 
phosphorylation of TFs by cyclin/Cdks either promotes cell cycle progression (e.g., 
FOXM1 and FOXO) or inhibits tissue differentiation (e.g., MyoD and Ngn2).  In 
contrast, Cdk-dependent phosphorylation does not simply inhibit the function of Otx2 in 
differentiation, but at the same time converts it to function in proliferation.  Thus, this 
study has shown a new category of TFs, in which post-translational modification of a 
single TF converts from a differentiation- to proliferation-orientated role.  
 
Repression activity by phosphorylated Otx2 and XXXX  
It is not well understood how Otx2 properly functions as an activator or a repressor for 
its target genes.  An answer to this question was reported (Yasuoka et al., 2014), 
showing that Otx2 functions as an activator together with Lim1 and also as a repressor 
 57 
together with Gsc, suggesting that the combination with partner proteins determines 
transcriptional activity of Otx2.  This combinatorial regulation may dominate over 
phosphorylation states because the Otx2-4A construct, which does not have repression 
activity by itself (Fig. 25K), still exert repressive activity together with Gsc for repressing 
the meis3-D2-luc reporter (Fig. 25L,M).  However, it should be noted that gsc is not 
expressed, in the neural plate, and it is not known yet what is a partner protein of Otx2 
for repressing meis3 and gbx2.  In this study, I demonstrate a possible partner TF of Otx2 
in the neural plate, XXXX.   
 
How does Otx2 coordinate its activator and repressor functions for development? 
Based on these lines of evidence together with other observations, I propose a model for 
Otx2 functions (Fig. 27).  In this model, during cell cycle progression (in proliferation), 
Otx2 is phosphorylated by cyclin/Cdk and Akt upon growth stimulation, and 
phosphorylated Otx2 is able to interact with Tle1 and XXXX to repress p27xic1, and, in 
turn, derepresses cyclin/Cdk activity, thereby forming a positive feedback loop (Fig. 27, 
upper).  In the ectoderm, phosphorylated Otx2 also represses posterior genes (gbx2 and 
meis3) and activates anterior genes (xcg1, rax) to establish anteroposterior patterning.  
When growth stimuli are reduced, and the cell cycle is arrested, unphosphorylated Otx2 
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functions as an activator for anterior development (cement gland formation and retinal 
differentiation) (Fig. 27, lower).  Thus, Otx2 has ability to orchestrate cell proliferation 
and differentiation through changing its phosphorylation states.  This model is 
consistent with the expression patterns of related genes.  The ANE (future forebrain and 
midbrain), which expresses otx2 as well as cyclin and cdk genes (Fig. 24F) (Vernon and 
Philpott, 2003), exhibits high mitotic rate with no expression of p27xic1 (Fig. 24G,H).  
By sharp contrast, the posterior neuroectoderm, which expresses no otx2 but cyclin and 
cdk to a lesser extent (Fig. 24F) (Vernon and Philpott, 2003), exhibits low mitotic rate 
with the expression of p27xic1 (Fig. 24G,H).  However, at the tailbud stages (stages 20-
40), the developing retina expresses both otx2 (Wang and Harris, 2005 Viczian et al., 
2003) and p27xic1 (Ohnuma et al., 1999).  It was reported that, in developing retinal 
cells, otx2 is transcribed, but not translated during the early to mid-retinal neurogenesis 
(stages 33, 37), and Otx2 protein was only detectable from late retinal neurogenesis (stage 
38) in bipolar cells (Decembrini et al., 2006).  Therefore, the absence of the Otx2 protein 
at the early to mid-retinal neurogenesis in the developing retina may explain 
colocalization of otx2 and p27xic1 mRNAs (Decembrini et al., 2006).   
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Notably, both Otx2-4E and -4A upregulate xcg1 (Fig. 25G,H), and this activity needs 
the activation domain (Fig. 25I,J), implying that phosphorylated Otx2 retains 
transactivation activity, consistent with reporter analysis (Fig. 25N), and that Otx2 can 
directly upregulate xcg1 as has been shown (Gammill and Sive, 1997).  During cement 
gland formation, xcg1 appears to be expressed in both proliferating and non-proliferating 
cells because the expression of xcg1 starts at the gastrula stage in the anterior-most 
ectoderm at the dorsoventral border (Gammill and Sive, 1997 Gammill and Sive, 2001), 
and continues during neurula stages beyond stage 18, at which cell proliferation is 
undetectable (Saka and Smith, 2001).  This observation is consistent with the data that 
Otx2-4E and 4A both activate xcg1 expression, supporting the model that activator 
activity of Otx2 is unchanged by phosphorylation.   
In eye formation, it was reported that expression of a repressor form of Otx2 (Otx2-
EnR) by mRNA injection in Xenopus embryos results in small eye or eyeless phenotype 
(Isaacs et al., 1999), and that expression of another type of repressor form, EnR-Otx2, in 
chick eyes by electroporation caused pigmentation defects of the retinal pigment 
epithelium and the reduction of pax6 (Nishihara et al., 2012).  These activities of 
repressor forms of Otx2 are similar to that of Otx2-4E in Xenopus embryos (Fig. 20E and 
Fig. 21R,S), consistent with the repressor activity of Otx2-4E (Fig. 25K).  In contrast 
with Otx2-4E, Otx2-4A expanded the expression of rax at early neurula stage (Fig. 21D) 
without stimulating cell proliferation (Fig. 22D,H); at later stages, Otx2-4A expanded the 
expression of pax6 (retina) but inhibited pax2 (optic stalk) on the ventral side, leading to 
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ventral expansion of the retina.  These data suggest that Otx2-4A can expand the eye 
field, and subsequently alter patterning of the neural retina and optic stalk.  In other 
words, enlarged eye phenotypes by Otx2-4A is caused by changes in patterning, not by 
proliferation.  Our data is reminiscent of the previous report on the function of Otx2 for 
Xenopus retina formation, in which an activator type of Otx2 (Otx2-VP16) promotes the 
bipolar cell fate without stimulating retinal proliferation (Viczian et al., 2003), supporting 
the possibility that unphosphorylated Otx2 acts mainly as an activator in retina formation.   
Several heterozygous Otx2 mutations in human were reportedly linked with severe 
ocular malformation.  For example, point mutations of P133T, P134A, and P134R, 
which occur near one of the four putative phosphorylation sites, S132, found in our study 
(see Fig. 15), are associated with microphthalmia, anophthalmia, sclerocornea and retinal 
detachment (Beby and Lamonerie, 2013).  It is not certain whether these mutations 
actually affect phosphorylation of Otx2, and if it affects the interaction with putative 
binding partners of Otx2, but it is possible to speculate that ocular defects in human are 
caused by the alteration of phosphorylation states of Otx2.   
 
 
In summary, I demonstrated that Otx2 undergoes phosphorylation in vivo, and that 
phosphomimetic and non-phosphorylatable mutants of Otx2 exhibit distinct activities in 
cell proliferation, patterning and differentiation in Xenopus embryos.  In vivo analysis 
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of the phosphorylation sites, such as a mutated gene knock-in approach, is now awaited 
to explore the role of phosphorylated Otx2 in embryonic development.   
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General Discussion 
To understand the molecular mechanisms of gene regulation during development, it is 
important to elucidate not only genome-wide binding profiles of individual transcription 
factors (TFs) to cis-regulatory modules (CRMs) near target genes together with their loss-
of- and gain-of-function data, but also the regulation of individual TFs at the protein level, 
such as the combinatorial interplay among TFs and their binding partners or cofactors as 
well as the post-translational modification of TFs.  In this thesis, I investigated the 
molecular mechanism of how transcriptional activities of Otx2 are regulated by the 
combination with XXXX and YYYY, and by its phosphorylation states in developmental 
processes, such as the patterning of neuroectoderm and early eye formation in Xenopus.   
I started this study by investing two uncharacterized genes, xxxx and yyyy, which are 
expressed in the anterior neuroectoderm (ANE), and found that these two genes are 
involved in the gene cascade for eye development at positions downstream of Otx2.  
This finding led me to hypothesize functional and physical interactions of XXXX and 
YYYY with Otx2.  In Chapter I, I found that XXXX enhances the gene repression 
activity of Otx2, whereas YYYY inhibits the gene activation activity of Otx2.  From the 
data of WISH and RNA-seq, xxxx and yyyy are maternally expressed in the animal pole 
(Fig. 6), in which otx2 is not expressed (Sudou et al., 2012), suggesting the possibility 
that XXXX and YYYY associate with other TFs rather than Otx2.  Such TF could be a 
maternally expressed gene, otx1, because the possible phosphorylation sites are conserved 
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between Otx1 and Otx2 (Fig. 15).  In chapter II, I focused on post-translational 
modifications of Otx2, and found that the modification is phosphorylation.  Then, I 
investigated the role of phosphorylation at the three possible Cdk sites and one possible 
Akt site by using phosphomimetic and non-phosphorylatable mutants of Otx2.  
Although these data in this thesis obtained from overexpression approach, the differences 
of the activities between phosphomimetic or non-phosphorylatable Otx2 were clearly 
shown, thereby reasonably speculating in vivo functions of phosphorylated and 
unphosphorylated Otx2 proteins.  It would now be necessary to carry out knock-in 
experiments with a phosphomimetic or non-phosphorylatable otx2 gene for obtaining in 
vivo relevance data, but those are not feasible at this moment, in the Xenopus system.  In 
near future, it may be possible to examine this by CRISPR-Cas9-mediated generation of 
knock-in and knock-out approaches.   
My data suggest that phosphorylation of Otx2 confers repression activities of Otx2, 
otherwise functioning as a transactivator on its own.  Importantly, the interaction of 
Otx2 with Tle1 and XXXX is dependent on the phosphorylation of Otx2 (Fig. 25O and 
26A).  By contrast, Otx2 expressed in the head organizer does not require 
phosphorylation for interacting with Goosecoid to repress target genes (Fig. 25L,M).  
Thus, the data in my thesis suggest various regulatory modes of Otx2, which are 
summarized in Fig. 28.  To repress Otx2-target genes (Fig. 28A), Otx2 takes two modes, 
phosphorylation-dependent and -independent transrepression activity: (i) In the anterior 
neuroectoderm, where cell proliferation rate is high (see Fig. 24H), Otx2 requires 
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Cdk/cyclin-dependent phosphorylation to interact with Tle1 and XXXX, thereby linking 
cell proliferation and Otx2-mediated repression of target genes including p27 (see Fig. 
22D,H and 24D); and (ii) in the head organizer, where cell proliferation rate is low (see 
Fig. 24H), Otx2 does not require phosphorylation to repress its repressed target genes.  
Thus, phosphorylation-dependent regulation of Otx2 takes place in proliferative cells in 
the ANE, and the possible four phosphorylation sites (A-site and 3 C-sites) are 
evolutionarily conserved in vertebrates but only A-site and S132 are conserved in the 
echinoderm sea urchin, only S132 is conserved in the amphioxus, and no site seems to be 
conserved in the sea anemone Nematostella (Fig. 29), implying that this regulatory system 
might have started to be evolved in the common ancestor of deuterostomes and have been 
established in the common ancestor of vertebrates, whereas the amphioxus lost A-site.  
This evolutionary scenario of the Otx2 regulatory system might be related to the 
evolutionary development of the ANE in the chordate lineage. 
For activated target genes (Fig. 28B), Otx2 could upregulate them regardless of its 
phosphorylation stage in the case of the cement gland (Fig. 25G,H), but, in the 
neuroectoderm, phosphorylated Otx2 may tend to be recruited in a repression complex 
by interacting with XXXX, thereby reducing the contribution of Otx2 to activation of 
target genes.  In the head organizer, Otx2 requires a partner TF like Lim1 to activate 
target genes, because Otx2 alone does not confer the organizer activity when expressed 
alone in the ventral region (Yasuoka et al., 2014).  The third regulatory mode of Otx2 is 
shown in Fig. 28C, in which YYYY inhibit Otx2 transactivation activity, but whether 
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YYYY inhibits binding of Otx2 to a coactivator (p300) or CRMs of target genes remains 
to be elucidated.   
Thus, post-translational regulation of Otx2 repressor activity (Chapter II) in addition 
to combinatorial regulations with partner TFs (Chapter I) may allow Otx2 to play versatile 
roles during development.  As exemplified by Otx2, other TFs could be modulated by 
post-translational modifications including phosphorylation, ubiquitination, methylation, 
and so on, and by combinations of partner TFs as well as coactivators or repressors, 
thereby generating the diversity of multiple outputs in gene regulation for cellular and 
developmental processes.  Further elucidation of how TFs are regulated at various levels 
is necessary to understand the general principal of gene regulatory networks during 
development including cell proliferation, patterning, and differentiation.   
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Conclusion 
The thesis study has shown that XXXX and YYYY are involved in eye development in 
Xenopus, and both interact with Otx2 to modulate transcriptional activities of Otx2.  I 
also have shown that Otx2 undergoes phosphorylation in vivo, and that phosphomimetic 
and non-phosphorylatable mutants of Otx2 exhibit distinct activities in cell proliferation, 
patterning, and differentiation in Xenopus embryos.  Based on these findings, the 
combinatorial regulation with XXXX and YYYY, and post-translational regulation of 
Otx2 bring a proper gene expression of Otx2 for cell proliferation, the specification of the 
eye field and the patterning of neuroectoderm.  
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Experimental procedures 
 
cDNA cloning, sequence analysis, and constructs 
EST clones of xxxx (clone name XXXX) and yyyy (YYYY) in X. laevis were previously 
reported (Takahashi et al., 2005).  Dr. Mamada PCR-amplified the full-length cDNA for 
yyyy and a 3’-portion of the xxxx and cloned them into the pCSf107-mT vector, which 
contains SP6 terminator sequences downstream of the SV40 polyadenylation signal (Mii 
and Taira, 2009).  The 5’-portion of xxxx (2078 bp) was purchased from Open 
Biosystems (IMAGE 5065565) and cloned into the 3’-portion of the xxxx at BamHI/AflII 
sites of pCSf107-mT to reconstruct the full-length cDNA xxxx.S (accession number 
XM_018249724).  The coding sequences (CDSs) of XXXX [amino acid numbers, 1-
1136] and YYYY [1-545] were PCR-cloned into the pCSf107mT, pCSf107_Venus_mT 
(for Venus constructs), pCSf107_MTmT (Myc constructs) and pCSf107_4HAmT (HA 
constructs) vectors (Shibano et al., 2015).  PCR fragments of deleted CDSs of XXXX 
(BTB domain [1-581]), ZF domain [582-1136]) were cloned into the pCSf107-
Venus_mT.  Predicted domain search was done using Pfam 
(http://www.sanger.ac.uk/Software/Pfam/).  Point mutants and deletion constructs of 
Otx2 were made by using PCR-mediated methods.  PCR fragments of Otx2 mutants 
were cloned into the pCSf107mT, pCSf107_MTmT and pCSf107_4HAmT vectors.  To 
construct the stable mutant of cyclin B1, pGEX-GST-ΔN106cyclin B1 (Iwabuchi et al., 
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2002) was re-cloned into pCSf107_HAmT.  To construct the stable mutant of cyclin A1, 
pGEM-Δcyclin A (deletion of 55 amino acids from the N terminus of the protein) gifted 
by Dr. Furuno (Hiroshima University) was re-cloned into pCSf107_HAmT.  All 
constructs made in this study are listed in Table. 1.   
 
Xenopus embryo and microinjection 
Xenopus laevis and Xenopus tropicalis embryos were obtained by artificial fertilization, 
dejellied, and incubated in 0.1x Steinberg’s solution (Peng, 1991).  Embryos were 
staged according to the normal table of Nieuwkoop and Faber (Nieuwkoop and Faber, 
1967).  Microinjection of mRNA or antisense morpholino oligos (MOs) were done with 
a fine glass capillary and a pneumatic pressure injector IM300 (Narishige) in 3% Ficoll 
in 1x Modified Bath’s solution (Peng, 1991).  Injected embryos were kept in 3% Ficoll 
in 1x Modified Bath’s solution for 2–3 h, transferred into 0.1x Steinberg’s solution 
containing 50 µg/ml gentamicin sulfate, and incubated until embryos reached the 
appropriate stages.  For mRNA synthesis, pCSf107mT constructs, which possess 4x 
SP6 terminators, were transcribed with SP6 polymerase (mMESSAGE mMACHINE SP6 
kit, Ambion).  mRNAs were injected into one or two dorsal blastomeres of 2- or 4-cell 
stage embryos.  Nuclear β-galactosidase (nβ-gal) mRNA (50-100 pg/embryo) or eGFP 
mRNA (250 pg/embryo) was co-injected for lineage tracing.  Antisense and standard 
control MOs were dissolved in water and injected into a dorsal blastomere at 4-cell stages 
in X. tropicalis embryos.  FITC-dextran (5 ng/embryo) was coinjected for lineage 
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tracing in MO-injected experiments.  MOs against sequences near the start codon of 
xxxx and yyyy were obtained from Gene Tools: zbtb11-MO, 5’- 
ccaggtagctctcctcgttagacat-3’; yyyy-MO, 5’-cctcgctcttggtggaagtcattgt-3’ (antisense ATG 
codons are underlined).  Standard control MO (control-MO) targeting a beta-globin 
intron was used as a negative control: 5’-cctcttacctcagttacaatttata-3’.  Sequences and 
specificities of antisense MOs for X. tropicalis otx2 and otx5 were described previously 
(Yasuoka et al., 2014).   
 
Observation of subcellular localization of Venus-fused XXXX constructs and YYYY by 
confocal microscopy 
mRNA for Venus-XXXX constructs or -YYYY was injected into one blastomere at the 
4-cell stage.  Injected gastrula embryos were fixed in MEMFA (0.1 M MOPS, pH 7.4, 
2 mM EGTA, 1 mM MgSO4, 3.7% formaldehyde) for 1 hour, followed by removing the 
vitelline membrane, and washed three times with MEM (0.1 M MOPS, pH 7.4, 2 mM 
EGTA, 1 mM MgSO4).  Confocal microscopic analyses were performed with LSM 710 
(Zeiss).   
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Whole-mount in situ hybridization (WISH) 
WISH was performed according to Harland (Harland, 1991) with BM purple (Roche) as 
a substrate.  Antisense xxxx and yyyy probes were transcribed with T7 RNA polymerase 
from BamHI-linearized pCSf107-xxxx-T and pCSf107-yyyy-T plasmids.  Other 
antisense RNA probes were transcribed from linearized plasmids as described in Table. 
2.   
 
Western blot analysis 
Lysates were prepared from embryos (stages 10-10.5 otherwise mentioned) that had been 
injected with mRNA into both blastomeres in the animal pole region at the 2-cell stage.  
SDS-polyacrylamide gel electrophoresis (PAGE) was carried out with 7.5-10% 
polyacrylamide gels for detecting the bands of XXXX and YYYY, and with 12-12.5% 
polyacrylamide gels for detecting modified bands of Otx2.  Western blotting was 
performed essentially as described (Shibano et al., 2015), using anti-Myc (9E10, 1:10000 
dilution), anti-HA (12CA5, 1:10000), anti-GFP IRDye 800 conjugated (Rockland 
Immunochemicals Inc., 600-132-215, 1:5000), anti-Otx2 (Sudou et al., 2012, 1:2500), 
and anti-p44/42 MAP kinase and anti-phospho-p44/42 MAP kinase (CST inc., 1:2500) 
antibodies.  For secondary antibodies, ‘Goat anti-Mouse IgG (H+L) Highly Cross-
Adsorbed Secondary Antibody and Alexa Fluor 680’ (Invitrogen, A21058, 1:7500) and 
anti-rabbit IRDyeR  800 conjugated antibodies (Rockland, 611-132-122, 1:5000) were 
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used for detecting with the Odyssey Infrared Imaging system (LI-COR Biosciences)., and 
Peroxidase AffiniPure F(ab’)2 Fragment Goat Anti-Rabbit IgG F(ab’)2, Fragment Specific 
(Jackson Immuno Research inc., 111-036-047, 1:5000) was used for detecting with 
enhanced chemiluminescence (Amersham ECL prime) (GE Healthcare, RPN2236).   
 
Co-immunoprecipitation assay 
mRNAs were injected into the animal pole region of 2-cell stage X. laevis embryos.  
Injected embryos were cultured at 14-21°C until the gastrula stages (stages 10.5-11), 
homogenized in 500 µl lysis buffer (50 mM Tris-HCl, pH 8.0, 5 mM EDTA, 100 mM 
NaCl, 10% glycerol, 8 mM DTT, 40 µg/ml leupeptin, 20 µg/ml aprotinin, 1 mM PMSF) 
containing 0.1% NP40.  The lysate was centrifuged at 13,000 rpm (16,000 xg) for 20 
minutes at 4°C, and the 400 µl supernatant was transferred into a new tube.  The 
supernatant was incubated with anti-Myc or anti-HA antibody at 4°C for more than 2 
hours.  Thereafter, 20 µl of protein G/protein A Sepharose beads (Merck IP05) were 
added and incubated more than 2 hours.  Subsequently, the Sepharose bead were washed 
six times with lysis buffer.  Bound proteins were eluted by boiling in 2×SDS sample 
buffer, separated by SDS-PAGE (7.5% gel, 10% gel or 12.5% gel), and analysed by 
western blotting with anti-Myc or anti-HA or anti-GFP antibodies.   
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Luciferase reporter assays 
Embryos were injected SOP-FLASH, pGL4p-meis3-D2-luc, or pGL4.23-wnt8-U1-luc 
reporter with mRNAs into two dorsal animal blastomeres at the 2- or 4-cell stage.  Five 
pools of three injected embryos were assayed for luciferase activity at stage 10.5 for 
pGL4p-meis3-D2-luc reporter or pGL4.23-wnt8-luc reporter, and at stage 12 for SOP-
FLASH assay.   
 
In vitro translation and protein phosphatase treatment 
In vitro translation was performed using the TNT SP6 Quick-Coupled 
Transcription/Translation System (Promega) as described (Yamamoto et al., 2003).  For 
λ-protein phosphatase (λ-PP) treatment, embryonic lysate was incubated in 1× λ-PP 
buffer with 1 µl ofλ-PP (NEB) at 37 °C for 1 hour, and analysed by western blotting.   
 
Immunoprecipitation (IP) assays for putative phosphorylated Akt sites and the detection 
of endogenous Otx2 protein 
Possible Akt sites of Otx2 were searched for the database PhosphoSitePlus, 
(www.phosphosite.org/).  Immunoprecipitates with anti-Myc antibody were boiled in 
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2×SDS sample buffer, and analysed by western blotting with anti-Phospho-Akt Substrate 
antibody (CST inc., 110B7E).  To detect the endogenous Otx2, we modified the 
preparation of embryonic lysate.  Xenopus neurula embryos (approximately 800 
embryos) were homogenized with 2.5 µl lysis buffer A (50 mM Tris-Cl, pH 8.0, 10% 
glycerol, 0.1%NP-40, 40 g/ml aprotinin, 20 µg/ml leupeptin, 1 mM PMSF) plus 400 
mM NaCl per embryo, and homogenates were centrifuged at 4°C for 1hr at 13,000 rpm 
(16,000 xg).  Supernatants were diluted four times with buffer A, and centrifuged at 4°C 
for 1hr at 13,000 rpm.  Eleven ml of Lysate were incubated with 5 µg of the anti-Otx2 
antibody (Sudou et al., 2012) and 25 µl of protein A-agarose beads (Roche).  The 
Sepharose beads were washed six times with lysis buffer.  The resulting 
immunoprecipitates were solubilizing by boiling in 2×SDS sample buffer, and analysed 
by SDS-PAGE with a 15% polyacrylamide gel and western blotting with anti-Otx2 
antibody (Abcam, ab21990, 1:2000 dilution). 
 
Quantitation of the eye size in tailbud stage embryos 
Embryos injected for phenotypic analysis were reared until stages 38-42 and fixed with 
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MEMFA for 1 hour.  Experiments were carried out with at least three clutches.  The 
lengths of semi-major and semi-minor axes of the eye vesicle were measured, and the eye 
size were calculated by the formula for the area of an ellipse.   
 
Immunostaining for PH3 and DAPI nuclear staining  
mRNA or MO with eGFP mRNA or FITC dextran, respectively, as a lineage tracer was 
injected into one blastomere at the 4-cell stage.  Injected gastrula or neurula embryos 
were fixed with MEMFA for 1 hour, during which the vitelline membrane was manually 
removed, dehydrated with methanol, and stored at -20°C.  Fixed embryos were 
rehydrated sequentially in 75% and 50% methanol, 25% methanol/75% TBT (25 mM 
Tris-Cl, pH 7.4, 137 mM NaCl, 2.7 mM KCl, 0.2% BSA, 0.1% TritonX-100), then TBT, 
and blocked with TBTS (10% lamb serum in TBT) at room temperature for 1 hour.  
Treated embryos were incubated overnight at 4°C with rabbit Anti-phospho-Histone H3 
(Ser10) Antibody (Millipore, 1:500 dilution), and washed 6 times with TBT.  Embryos 
were incubated over 3 hours at room temperature with goat Alexa Fluor 555-conjugated 
anti-rabbit IgG antibody (Molecular Probes, 1:500 dilution) as secondary antibody.  
Nuclei were stained with 400 ng/ ml DAPI.  Confocal microscopic analysis was 
performed with LSM 710 (Zeiss).  Embryos with a lineage tracer in the ANE were 
selected for counting PH3- or DAPI-positive nuclei in an area (0.44 mm2) in the ANE on 
the injected or uninjected side.  The effect was scored by dividing the number of nuclei 
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on the injected side with that on the uninjected side.  The statistical significance (P-
value) was calculated using Student’s t-test after a one-way analysis of variance 
(ANOVA).  Eexperiments were carried out with four or three clutches for mRNA or MO 
injection experiments, respectively.   
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Tables and Figures  
Table. 1. The list of plasmid constructs 
Plasmid names Cloning sites Vectors Comments 
pCSf107_XXXX_T 
 
BamHI, XbaI pCSf107_mT aa 1-1136 (Full length: FL);  
XXXX.S (X. laevis), 
XM_018249724 
pCSf107_Myc-XXXX_T BamHI, AscI pCSf107_MycmT Replaced pCSf107-XXXX_T 
pCSf107_HA-XXXX_T BamHI, AscI pCSf107_HAmT Replaced pCSf107-XXXX_T 
pCSf107_Venus-XXXX_T BamHI, XbaI pCSf107_venus-mT  
pCSf107_Venus-BTB_T BamHI, XbaI pCSf107_venus-mT aa 1-581 (N-terminal BTB 
domain) 
pCSf107_Venus-ZF_T BamHI, XhoI pCSf107_venus-mT aa 582-1136 (C-terminal Zinc 
fingers) 
pCSf107_Venus-NLS-BTB_T BamHI, SacII pCSf107_Venus-NLS-mT Replaced pCSf107_Venus-
BTB_T 
pCSf107_YYYY_T BamHI, XbaI pCSf107_mT aa 1-545 (Full length: FL);  
YYYY.L (X. laevis),  
pCSf107_Venus-YYYY_T BamHI, XbaI pCSf107_venus-mT  
pCSf107_XXXX-ATG-eGFP_T BamHI, XbaI pCSf107_mcs2-eGFP-C2mT  
pCSf107_YYYY-ATG-eGFP_T BamHI, XbaI pCSf107_mcs2-eGFP-C2mT  
pCSf107_MycOtx2FL_T BamHI, XbaI pCSf107_MTmT aa 1-288 (Full length: FL);  
Otx2.S (X. laevis), 
NP_001084160 
pCSf107_MycOtx2FL-K87Q_T BamHI, XbaI pCSf107_MTmT  
pCSf107_MycOtx2FL-K87E_T BamHI, XbaI pCSf107_MTmT  
pCSf107_MycOtx2HD_T BamHI, XbaI pCSf107_MTmT aa 1-96 (constructed by Ms. 
Hosono) 
pCSf107_MycOtx2ΔAD_T BamHI, XbaI pCSf107_MTmT aa 1-184 (constructed by Ms. 
Hosono) 
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pCSf107_MycOtx2AD_T BamHI, XbaI pCSf107_MTmT aa 185-288 (constructed by 
Ms.Hosono) 
pCSf107_MycOtx2ΔRD_T BamHI, XbaI pCSf107_MTmT aa 1-96/185-288 (constructed by 
Ms. Hosono) 
pCSf107_MycOtx2ΔAD-T115A_T BamHI, XbaI pCSf107_MTmT  
pCSf107_MycOtx2ΔAD-S116A_T BamHI, XbaI pCSf107_MTmT  
pCSf107_MycOtx2ΔAD-S122A_T BamHI, XbaI pCSf107_MTmT (constructed by Mr. Minami) 
pCSf107_MycOtx2ΔAD-S123A_T BamHI, XbaI pCSf107_MTmT (constructed by Mr. Minami) 
pCSf107_MycOtx2ΔAD-S132A_T BamHI, XbaI pCSf107_MTmT (constructed by Mr. Minami) 
pCSf107_MycOtx2ΔAD-S153A_T BamHI, XbaI pCSf107_MTmT (constructed by Mr. Minami) 
pCSf107_MycOtx2ΔAD-S158A_T BamHI, XbaI pCSf107_MTmT (constructed by Mr. Minami) 
pCSf107_MycOtx2ΔAD-S161A_T BamHI, XbaI pCSf107_MTmT (constructed by Mr. Minami) 
pCSf107_MycOtx2ΔAD-3A_T BamHI, XbaI pCSf107_MTmT S116A, S132A, S158A  
pCSf107_MycOtx2ΔAD-4A_T BamHI, XbaI pCSf107_MTmT T115A, S116A, S132A, S158A 
pCSf107_MycOtx2ΔAD-2A(S158)_T BamHI, XbaI pCSf107_MTmT S116A, S132A 
pCSf107_MycOtx2ΔAD-2A(S132)_T BamHI, XbaI pCSf107_MTmT S116A, S158A 
pCSf107_MycOtx2ΔAD-2A(S116)_T BamHI, XbaI pCSf107_MTmT S132A, S158A 
pCSf107_Otx2-WT_T BamHI, XbaI pCSf107_mT Wild type: WT 
pCSf107_Otx2-4E_T BamHI, XbaI pCSf107_mT T115E, S116D, S132E, S158E 
pCSf107_Otx2-T115A_T BamHI, XbaI pCSf107_mT  
pCSf107_Otx2-3A_T BamHI, XbaI pCSf107_mT S116A, S132A, S158A 
pCSf107_Otx2-4A_T BamHI, XbaI pCSf107_mT T115A, S116A, S132A, S158A 
pCSf107_Otx2-A2A(S116)_T BamHI, XbaI pCSf107_mT T115A, S132A, S158A 
pCSf107_Otx2-A2A(S132)_T BamHI, XbaI pCSf107_mT T115A, S116A, S158A 
pCSf107_Otx2-A2A(S158)_T BamHI, XbaI pCSf107_mT T115A, S116A, S132A 
pCSf107_Otx2ΔAD-4A_T BamHI, XbaI pCSf107_mT  
pCSf107_Otx2ΔAD-4E_T BamHI, XbaI pCSf107_mT  
pCSf107_HA-cyclin A1*_T BamHI, XhoI pCSf107_4HAmT Replaced Δcyclin A1 (from Dr. 
N. Furuno) 
pCSf107_HA-cyclin B1*_T BamHI, 
EcoRI 
pCSf107_4HAmT Replaced GST-ΔN106cyclin B1 
(Iwabuchi et al., 2002) 
pCSf107_p27xic1_T BamHI, XhoI pCSf107_mT  
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pCSf107_HATLE1_T AgeI, XbaI pCSf107_4HAmT Replaced pCSf107-TLE1  
pCS2+Gsc NcoI, SalII pCS2+  
pCSf107_pax6_T SfuI, NotI pCSf107_mT replaced pCS105-pax6 
Note: the postfix “_T” indicates the presence of SP6/T7 terminators at the end of the transcribed 
region. 
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Table. 2. The list of cutting sites and RNA polymerases for the in vitro transcription of 
anti-sense RNA probe. 
Plasmid names Cutting sites RNA polymerase 
pCSf107_XXXX_T BamHlI  T7  
pCSf107_YYYY_T BamHlI  T7  
pCSf107_p27xic1_T BamHlI  T7  
pCS2+_Sox2 HindIII T7 
pCSf107_Otx2-WT_T BamHlI  T7  
pBS SK(-)gbx2 EcoRI  T3  
pCS107BSX_rax XhoI  SP6 
pCSf107_pax6_T SalI  T7  
pDH105(CS2)_XSix3  T7 
BS4A 3(X pax2-2a) EcoRI T3 
pBSK_xcg1 NotlI  T3  
 forebrain/ midbrain 
forebrain/midbrain 
formation 
eye field 
formation 
anterior 
posterior 
eye field 
retina 
optic  
vesicle 
eye vesicle 
formation 
optic cup 
optic 
 stalk 
lens optic 
 stalk 
Fig. 1. Developmental processes of vertebrate eye.   
In the neurula embryo, the neural plate is divided into the presumptive 
forebrain-midbrain region and hindbrain region, respectively, in terms of the 
anteroposterior position.  As the first step of vertebrate eye development, the 
eye field, in which the eyes will be formed is specified in the center of the 
forebrain.  The eye field is gradually separated into two bilateral regions to give 
rise to the optic vesicles, and subsequently the optic cup and retina are formed.  
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Fig. 2. A model of  eye field formation in the anterior neural plate. 
tbx3 
rax pax6 
six3 
lhx2 
tll 
six6 
otx2 
(A) Expression patterns of TFs otx2 (forebrain and midbrain, light blue), gbx2 
and meis3 (hindbrain, blue), rax and pax6 (eye field, magenta) in early Xenopus 
neurula embryos.  For the anteroposterior patterning in the neuroectoderm, otx2 
is expressed in the forebrain and midbrain, and gbx2 and meis3 are expressed in 
the hindbrain.  During late gastrulation, EFTF genes, rax and pax6, are 
expressed in the center of the region where otx2 is expressed.  (B) A schematic 
model of gene expression patterns of known EFTFs in early neurula (stages 12-
12.5, left) and mid-neurula (stage 15, right) embryos.  (C) A gene cascade of 
eye field specification.  In the early step of eye field specification, otx2 
upregulates the expression of rax and subsequently the expression of pax6 is 
activated, and otx2 represses the expression of tbx3.  During mid-step for eye 
field specification, rax in turn represses otx2, forming a negative feedback loop 
between otx2 and rax.  In addition, the expression of other EFTFs (six3, lhx2, 
six6, and tll) downstream of pax6 starts to be expressed.   
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Fig. 3〜Fig. 12については、5年以内に雑誌で
刊行予定のため、非公開。 
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Fig. 13. Expression patterns and gene interactions involved in the patterning of 
eye vesicle.   
(A) Expression patterns of otx2, pax6 and pax2 in the diencephalon, neural 
retina and optic stalk.  (B) A model for gene interactions for the establishment 
of the territories of eye vesicle.  The reciprocal repression of Otx2 and Pax2 
determines the segregation of RPE (the retinal pigment epithelium)/OS (optic 
stalk), and the similar mechanism is proposed for Pax2 and Pax6 interaction in 
the establishment of RPE/NR (neural retina).  It remains to be elucidated 
whether Otx2 contributes to the direct regulation of pax6.   
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Cdk sites: S*/T*-P       
Akt sites: R/K-X2-S*/T* 
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Fig. 14. Exogenous Otx2 is phosphorylated.   
(A) Schematic structures of Myc-Otx2 and deletion constructs.  The 
homeodomain (HD), repression domain (RD) and activation domain (AD) are 
indicated.  A Myc-tag at the N-terminus is indicated as a yellow box.  White 
star, Akt site; pink stars, Cdk sites.  The regions of Otx2 constructs are indicated 
by thick lines and positions of amino acid residues are indicated in parentheses.  
(B) Amino acid sequences around the repression domain.  Colored cases 
indicate the consensus motif for Cdks (magenta) and Akt kinase (blue).  Bold 
cases indicate modified serine and threonine residues that were suggested in the 
experimental process (T115, S116, S132 and S158).  Under line, the eh1 motif 
of the repression domain.  Consensus motifs for Cdk and Akt are indicated at 
the bottom.  *, phosphorylated serine/threonine residues.  (C) Western blotting 
of Myc-Otx2ΔAD constructs, WT and alanine mutants at T115 (T115A), S116 
(S116A), S132 (S132A), S153 (S153A) and S158 (S158A).  (D) Western 
blotting of Myc-Otx2ΔAD (upper) and Myc-Otx2FL constructs (lower), WT, 
3A and 4A with or without λ-protein phosphatase (λ-PP) treatment.  (E) IP-
western assay.  Myc-Otx2ΔAD was immunoprecipitated with anti-Myc 
antibody, and subjected to western blotting with the anti-Phospho-Akt substrate 
antibody (upper) or anti-Myc antibody (lower).  3A, alanine mutant at S116, 
S132 and S158; 4A, alanine mutant at T115, S116, S132 and S158; uninj., 
uninjected control; orange arrowheads, bands resistant to λ-PP.  FL, full length; 
WT, wild type; blue arrowheads, nascent proteins; magenta arrowheads, 
modified proteins.  Size markers (kDa) are indicated on the right of panels 
(C,D,E). 
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Xl_Otx2.L       MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDILEALFAK 59 
Xl_Otx5.L       MMSYIKQ-PHYAVNGLTLAGTGMDLLHSAVGYPTNPRKQRRERTTFTRAQLDILESLFAK 59 
Xt_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Xt_Otx5         MMSYIKQ-PHYAVNGLTLAGTGMDLLHSAVGYPTTPRKQRRERTTFTRAQLDILEALFAK 59 
Dr_Otx2         MMSYLKQ-PPYTVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Dr_Otx5         MMSYMKQ-PHYSVNGLTLTGTGMDLLHSAVGYPNTPRKQRRERTTFTRAQLDVLEALFSK 59 
Gg_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Gg_Otx5         MMSYIKQ-PHYAVNGLTLAGPGMDLLHSAVGYPATPRKQRRERTTFTRAQLDILEALFAK 59 
Mm_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Mm_Crx          MMAYMNPGPHYSVNALALSGPNVDLMHQAVPYSSAPRKQRRERTTFTRSQLEELEALFAK 60 
Hs_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Hs_Crx          MMAYMNPGPHYSVNALALSGPSVDLMHQAVPYPSAPRKQRRERTTFTRSQLEELEALFAK 60 
                **:*::  * *:**.*:*: ..:**:* :* *.  *************:**: **:**:*  
  
Xl_Otx2.L       TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPSKKK 114 
Xl_Otx5.L       TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQ--STGQAKPRPAKKK 112 
Xt_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPSKKK 114 
Xt_Otx5         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQ--STGQAKPRPAKKK 112 
Dr_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Dr_Otx5         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQ-TSGQTKPRPPKKK 113 
Gg_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Gg_Otx5         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQ--SSGQPKARPAKKK 112 
Mm_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Mm_Crx          TQYPDVYAREEVALKINLPESRVQVWFKNRRAKCRQQRQQQKQQQQPPGAQTKARPAKRK 120 
Hs_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Hs_Crx          TQYPDVYAREEVALKINLPESRVQVWFKNRRAKCRQQRQQQKQQQQPPGGQAKARPAKRK 120 
                *:***:: ****************************     :***    .* * **.*:*  
  
Xl_Otx2.L       T----SPAREVSSE---SGTSGQFSPPCS---TSGPVISSSTAPVSIWSPASISPLSDPL 164 
Xl_Otx5.L       T----SPARETNSE---ASTNGQYSPPPPG--TAVTPSSSASATVSIWSPASISPIPDPL 163 
Xt_Otx2         P----SPAREVSSE---SGTSGQFSPPCS---TSVPVISSSTAPVSIWSPASISPLSDPL 164 
Xt_Otx5         T----SPARETNSE---ASTNGQYSPPPPG--TAVTPSSTASATVSIWSPASISPIPDPL 163 
Dr_Otx2         S----SPAREASSE---SGASGQFTPPSS---TSVPAISTTTAPVSIWSPASISPLSDPL 164 
Dr_Otx5         S----SPARDSSASEPSASTSGPYSPPPPPPGTAITP-SSSSATVSIWSPASISPLPDPL 168 
Gg_Otx2         N----SPAREVSSE---SGTSGQFTPPSS---TSVPTISSSSAPVSIWSPASISPLSDPL 164 
Gg_Otx5         P----TPPREAPND---AGGAGPYSPTQP----GPAGTPGSAAPVSIWSPASISPVPDPL 161 
Mm_Otx2         S----SPAREVSSE---SGTSGQFSPPSS---TSVPTIASSSAPVSIWSPASISPLSDPL 164 
Mm_Crx          AGTSPRPSTDVCTDP--LGISDSYSPSLP---GPSGSPTTAVATVSIWSPASEAPLPEAQ 175 
Hs_Otx2         T----SPAREVSSE---SGTSGQFTPPSS---TSVPTIASSSAPVSIWSPASISPLSDPL 164 
Hs_Crx          AGTSPRPSTDVCPDP--LGISDSYSPPLP---GPSGSPTTAVATVSIWSPASESPLPEAQ 175 
                      *. :   .    .  . ::*. .         . : *.******** :*:.:.   
  
Xl_Otx2.L       S---TSSS-CMQRS---YPMTYTQASGYSQG---YASSTSYFGGMDCGSYLTPMHHQLSG 214 
Xl_Otx5.L       S---AVTNPCMQRST-GYPMTYSQAPAYTQS---YGGSSSYFTGLDCGSYLSPMHPQLSA 216 
Xt_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLSG 214 
Xt_Otx5         S---AATTPCMQRSA-GYPMTYSQAPAYTQS---YGGSSSYFTGLDCGSYLSPMHPQLSA 216 
Dr_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLTG 214 
Dr_Otx5         S---APSTACLQRSS--YPMTYSQAPAYGQS---YAASSSYFTGLDCSSYLSPMHPQLSA 220 
Gg_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLPG 214 
Gg_Otx5         A---AGSAPGLPRSAPFSAAPYNQTAPYGQS---YGGSAAYFGGLDCGAYLSPMHPPLGA 215 
Mm_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLPG 214 
Mm_Crx          RAGLVASGPSLTSAP--YAMTYAPASAFCSSPSAYASPSSYFSGLDP--YLSPMVPQLGG 231 
Hs_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLPG 214 
Hs_Crx          RAGLVASGPSLTSAP--YAMTYAPASAFCSSPSAYGSPSSYFSGLDP--YLSPMVPQLGG 231 
                    . :   :  :    . .*  :. : ..   *...::** *:*   **:**   * .  
  
Xl_Otx2.L       PGATLSPMSTNAVTSHLNQSQAALSSQAYGASSLGFNSTADCLDYKDQTASWKLNFNA-D 273 
Xl_Otx5.L       PGATLSPIATPTMGSHLSQSPASLSAQGYGAASLGFTS-VDCLDYKDQTASWKLNFNATD 275 
Xt_Otx2         AGATLSPMGTNAVTSHLNQSPAALSSQAYGASSLGFNSTADCLDYKDQTASWKLNFNA-D 273 
Xt_Otx5         PGATLSPIATPTMGSHLSQSPASLSAQGYGASSLGFTS-VDCLDYKDQTASWKLNFNATD 275 
Dr_Otx2         PGSTLSPMSSNAVTSHLNQSPASLPTQGYGASGLGFNSTADCLDYKDQASSWKLNFNA-D 273 
Dr_Otx5         SGGALSPMSG-----ALSQSPASLSSQGYTAASLGFGT-VDCLDYKDQTSAWKLNFNAAD 274 
Gg_Otx2         PGATLSPMGANAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNA-D 273 
Gg_Otx5         PGAALSPLGAP-MGAHLTPSPAALSGQSFGAG-LGFGA-VDCLEYKEQAGAWKLNFNAAD 272 
Mm_Otx2         PGATLSPMGTNAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNA-D 273 
Mm_Crx          P--ALSPLSGPSVGPSLAQSPTSLSGQSYSTYSP-----VDSLEFKDPTGTWKFTYNPMD 284 
Hs_Otx2         PGATLSPMGTNAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNA-D 273 
Hs_Crx          P--ALSPLSGPSVGPSLAQSPTSLSGQSYGAYSP-----VDSLEFKDPTGTWKFTYNPMD 284 
                .  :***:.       *  * ::*. *.: :        .*.*::*: :.:**:.:*. *  
  
Xl_Otx2.L       CLDYKDQTSSWKFQVL 289 
Xl_Otx5.L       CLDYKDQ-SSWKFQVL 290 
Xt_Otx2         CLDYKDQTSSWKFQVL 289 
Xt_Otx5         CLDYKDQ-SSWKFQVL 290 
Dr_Otx2         CLDYKDQTSSWKFQVL 289 
Dr_Otx5         CLDYKDQ-NSWKFQVL 289 
Gg_Otx2         CLDYKDQTSSWKFQVL 289 
Gg_Otx5         CLDYKEQ-SSWKFQVL 287 
Mm_Otx2         CLDYKDQTSSWKFQVL 289 
Mm_Crx          PLDYKDQ-SAWKFQIL 299 
Hs_Otx2         CLDYKDQTSSWKFQVL 289 
Hs_Crx          PLDYKDQ-SAWKFQIL 299 
                 ****:* .:****:*  
 Fig. 15. Alignment of amino acid sequences of Otx2 and Otx5/Crx among vertebrates. 
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Abbreviations of species are Xenopus laevis (Xl), Xenopus tropicalis (Xt), 
Danio rerio (Dr), Gallus gallus (Gg), Mus musculus (Mm) and Homo sapiens 
(Hs).  Protein sequences were obtained from the NCBI database: Xl_Otx2.L 
(NP_001084955), Xl_Otx5.L (NP_001081916), Xt_Otx2 (NP_001016177), 
Xt_Otx5 (NP_001016021), Dr_Otx2 (NP_571326), Dr_Otx5 (NP_851848), 
Gg_Otx2 (NP_989851), Gg_Otx5 (NP_001288716), Mm_Otx2 
(NP_001273412), Mm_Crx (NP_031796), Hs_Otx2 (NP_001257453), Hs_Crx 
(AAH53672).  Boxes coloured in green, homeodomain; blue, SIWSPAS motif; 
yellow, repeated Otx tail motif; red, Otx2 mutation sites (P133 and P134) that 
were reportedly associated with human ocular malformation.  Blue or magenta 
letters, consensus motifs for Akt and Cdks.  Bold cases, putative 
phosphorylation sites of Otx2 as shown in this study.   
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Fig. 16. The detection limit of Otx2FL and phosphorylation of endogenous Otx2 
by western blotting.  
(A) Embryos were injected with Otx2FL mRNA at various doses as indicated.  
Modified bands of Otx2FL was clearly detected when Otx2FL mRNAs were 
exogenously injected with greater than 400 pg per embryo, but not less than 200 
per embryo.  Embryonic lysate of 0.42 embryo equivalent was loaded per lane.  
(B) Western blotting of endogenous Otx2 (left panel) and exogenous Otx2FL 
construct (right panel) with or without λ-PP treatment.  Otx2FL and endogenous 
Otx2 was detected with anti-Otx2 antibodies (A,B).  Blue arrowheads, nascent 
proteins; magenta arrowheads, modified proteins.   
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Fig. 17. Effects of MAPK and Cdk on modifications of exogenous Otx2.   
(A) No effect of constitutively active mutant of MAPKK (MAPKK*) on 
modifications of Otx2.  Western blotting of Myc-Otx2ΔAD co-expressed with 
MAPKK*.  The amounts of injected MAPKK** mRNA were as indicated.  
mRNAs were injected into the animal pole region of both blastomeres at the 2-
cell stage.  (B) Phenotypes of Myc-Otx2ΔAD, HA-cyclin B1* (stable mutants 
of cyclin B1), and HA-cyclin A1* (stable mutants of cyclin A1) overexpressing 
embryos.  Embryos were observed at the early blastula stage (animal pole 
view).  (C,D) Western blotting of Myc-Otx2ΔAD co-expressed with HA-cyclin 
B1* (C) or HA-cyclin A1* (D).  Lysate were treated with λ-PP as indicated.  
Myc-Otx2ΔAD and HA-cyclin B1* or HA-cyclin A1* were detected with anti-
Myc and anti-HA antibodies, respectively.  Lysates were prepared from 
embryos at stage 8 (C) or stage 9 (D).  White asterisks, cell cycle-arrested 
blastomeres. Scale bars, 500 μm.  
106 
A 
HD 
HD 
HD 
HD S 
A 
S 
A 
S 
S 
A 
A 
 116  132  158 
Myc-Otx2ΔAD  
constructs  
HD 
S158 
S132 
S116 
3A 
RD Myc 
2A 
WT S 
A 
A 
S 
A A A 
70 
WB:  
anti-Myc 
WB:  
anti-Myc 
44 
44 
44 
S158 S132 S116 3A 
＋ − ＋ − ＋ − ＋ − 
C 
WB:  
anti-HA 
HA- 
cyclin A1* ＋ − 
B 
WT S158 
＋ − ＋ − ＋ − ＋ − 
S132 S116 
WB:  
anti-HA 
HA- 
cyclin B1* ＋ − 
3A 
WT 
2A constructs 
Myc-Otx2ΔAD constructs 
2A constructs 
Myc-Otx2ΔAD constructs 
(kDa) 
(kDa) 
Fig. 18. Preference of cyclin B/Cdk and cyclin A/Cdks for Cdk sites of Otx2.   
(A) Schematic presentation of Myc-Otx2ΔAD with double (2A) and triple 
alanine (3A) mutations at S116, S132 and S158.  Yellow box, Myc-tag; black 
box, homeodomain (HD); blue box, repression domain (RD).  In the 2A 
constructs, for example, the S158 construct indicates mutations at S116 and 
S132.  S, serine phosphorylation sites (S116, S132, S158); A, alanine mutation.  
(B) Western blotting of Myc-Otx2ΔAD constructs (2A or 3A) co-expressed with 
(+) or without (-) HA-cyclin B1*.  (C) Western blotting of Myc-Otx2ΔAD 
constructs (2A or 3A) co-expressed with (+) or without (-) HA-cyclin A1*.  
Blue arrowheads, nascent bands; magenta arrowheads, modified bands; white 
arrowheads, additional modified bands at sites other than S116, S132 and S158.  
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Fig. 19. Effects of p27xic1 to phosphorylation of Otx2 and developmental 
changes of phosphorylation of Otx2. 
(A) Phenotype of p27xic1-overexpressing embryos (left) and western blotting of 
Myc-Otx2ΔAD co-expressed with p27xic1 (middle, right).  Co-injection 
(middle): Myc-Otx2ΔAD mRNA (500 pg/embryo) was coinjected with (lane 2) or 
without (lane 1) p27xic1 mRNA (2 ng/embryo) into one blastomere at the 2-cell 
stage.  Sequential injection (right): p27xic1 mRNA (1.5 ng/embryo) was injected 
into one blastomere at the 2-cell stage, then mRNAs for Myc-Otx2ΔAD (500 
pg/embryo) and p27xic1 (500 pg/embryo) were co-injected into the cleavage-
arrested blastomeres at the 32-cell stage equivalent (lane 4).  Myc-Otx2ΔAD 
mRNA was injected at the 2-cell stage as control (lane 3).  Lysates were prepared 
from embryos at stage 9 (lanes 1 and 2) or stage 9.5 (lanes 3 and 4).  White 
asterisks, cleavage-arrested blastomeres.  Scale bars, 500 μm.  (B) Developmental 
changes of phosphorylation of Otx2 as assayed by using Myc-Otx2ΔAD 
constructs. WT and alanine mutants of Otx2 in Myc-Otx2ΔAD constructs were 
analyzed from stages 5 to 10.5 as indicated.  TNT, in vitro translation products; 
blue arrowheads, nascent bands; magenta arrowheads, modified bands.   
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Fig. 20. Phosphomutants of Otx2 exhibit the distinct activity as assessed by 
developmental eye phenotype.  
(A-D) Eye phenotypes of Otx2 mutant-expressing embryos (stages 38-42).  
mRNA for Otx2 constructs were co-injected with nβ-gal mRNA as a tracer.  
Representative phenotypes in injected embryos (A-D): normal looking 
(normal), trace eye (trace), normal eye diameter with pigmentation defect at the 
ventral side (ventral defect) and enlarged retinal diameter with pigmentation 
defect at the ventral side (enlarged).  The white dashed lines indicate the 
diameter of the eye.  Anterior to the left, dorsal is up.  Scale bar, 500 μm.  (E) 
Activity of Otx2 mutants for eye malformation phenotypes.  The color bar (see 
panels A-D for color codes) indicates the percentages of the eye phenotype.  
Low-dose mRNA injection (20 pg/embryo) caused moderate phenotypes than 
high dose injection (40 pg/embryo).  n, total number of injected embryos.  (F) 
Quantitative assay for the ratio of the eye size in tailbud stage embryos (stages 
38-42).  **P<0.01 (t-test); error bars, s.e.m.; n=7 samples.  (G-H’) Transverse 
hemisection observations.  (G,G’) Globin injected control.  (H,H’) The enlarged 
eye phenotype of 4A-expressing embryo.  Bright field, G,H; DAPI staining, 
G’,H’.  Arrowheads, the retinal pigmentation defect at the ventral side.  Scale 
bar, 100 μm.   
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Fig. 21. Increased expression of eye marker genes by Otx2 mutant 4A.  
(A-T) mRNA for globin, WT, 4E or 4A (20 pg/embryo) was injected with nβ-
gal mRNA into the animal pole region of the dorsal-right blastomere at the 4-
cell stage, and embryos were subjected to WISH at early neurula stages (stages 
13-14) (A-H) and at late neurula stages (stages 18-20) (I-T).  MHB, the 
midbrain-hindbrain boundary; OS, optic stalk; OV, optic vesicle; Te, 
telencephalon, Di, diencephalon.  Arrowhead, the position of MHB; arrow, the 
expansion of pax6 expression to the anterior region.  Anterior view with dorsal 
up.  Scale bar, 500 μm.  (Q’-T’) Enlarged images of Q-T.  Black and white dash 
lines indicate diencephalon and optic vesicle regions, respectively, where pax6 
is expressed.  Scale bar, 100 μm.   
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Fig. 22. Phosphomimetic Otx2 mutant 4E stimulates cell proliferation. 
(A-C) mRNA for Otx2-WT (A), -4E (B) or -4A (C) together with that for eGFP 
as a tracer was injected in one blastomere at 2-cell stage.  4E and 4A are 
glutamate and alanine mutants, respectively, of full length Otx2 at T115, S116, 
S132 and S158.  Embryos were immunostained with anti-phospho-Histone H3 
(PH3) at the gastrula stage.  The dorsoanterior region was observed.  PH3-
positive nuclei were shown in red, Otx2 mutant-expressing cells (expressing 
eGFP) were shown in green.  White dash boxes in A-C correspond to enlarged 
area (A’-C”), respectively.  Scale bar, 200 μm.  (D) Quantitative assay for the 
ratio of PH3-positive nuclei.  (E-G) Representative images of DAPI-stained 
nuclei in Otx2-WT (E) or -4E (F) or -4A (G) expressing gastrula embryos.  The 
dorsoanterior region was observed.  Nuclei were shown in blue, Otx2 mutant-
expressing cells (expressing eGFP) were shown in green.  Red boxes in E, F and 
G correspond to enlarged area (E’-G”), respectively.  Scale bar, 200 μm (E-G); 
50 μm (E’-G”).  (H) Quantitative analysis for cell numbers.  More than 500 total 
nuclei were counted in one embryos, and 5 to 7 embryos were analysed for 
calculating the mean ratio (and s.e.m.) of the number of nuclei in injected 
versus uninjected areas.  **P<0.01 (t-test), *P<0.05 (t-test); error bars, s.e.m. 
(D,H).    
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Fig. 23. Reduction of cell proliferation by otx2/otx5 knockdown in Xenopus 
tropicalis embryos.   
Knockdown experiments were performed using Xenopus tropicalis.  (A,B) 
Effects of otx2/otx5-MO injection on mitotically active cells. White boxes, 
enlarged area (A’-B”).  (C) Quantitative analysis for the ratio of PH3-positive 
nuclei.  PH3-positive nuclei in an injected or uninjected area (0.072 mm2) in 
each embryo were counted (more than 60 nuclei in each area) with 9 embryos, 
and the ratio of the numbers of injected versus uninjected area was calculated 
for each embryo to obtain mean ± s.e.m. from 9 embryos.  The ratio of PH3-
positive nuclei in control MO-injected embryos was 1.15 ± 0.055 (mean ± 
s.e.m.), whereas that in otx2/otx5-MOs-injected embryos was 0.688±0.063, 
which significantly differed from the control (p = 4.95E-05).  (D,E) Effects of 
otx2/otx5-MO on cell density.  Red boxes, enlarged area (D’-E”).  (F) 
Quantitative analysis for the ratio of cell densities.  More than 500 total nuclei 
in each area (0.072 mm2) were counted in one embryo, and 9 embryos were 
analysed.  The ratio of cell density in control MO-injected embryos was 1.063 
± 0.034 (mean ± s.e.m.), whereas that in otx2/otx5-MOs-injected embryos 
was 0.906 ± 0.013, which differed from the control (p = 0.0015).  **P<0.01 (t-
test); error bars, s.e.m. (C,F).  Scale bar, 500 μm (A,B,D,E); 50 μm (A’-B”,D’-
E”,).  The amount of injected MO (pmol/embryo): control MO, 1; otx2/otx5, 0.5 
each.   
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Fig. 24. Phosphomimetic Otx2-4E mutant negatively regulates p27xic1 expression. 
(A) Genome browser representation showing occupancies of Otx2 and Tle1 in 
Xenopus tropicalis gastrula embryos for the p27xic1 gene.  (B-E) The WISH 
assay shows the expression of p27xic1 in Otx2 mutant-expressing embryos.  
mRNA (30 pg each) for globin (B), WT (C), 4E (D), or 4A (E) was injected 
with nβ-gal mRNA as a tracer into the animal pole region of the dorsal-left 
blastomere at the 4-cell stage.  The fractions indicate the proportion of the 
presented phenotype per total number.  Dorsal view with anterior up.  inj., 
injected side; uninj., uninjected side.  (C’,D’,E’) Enlarged image of C, D and E 
(white dashed box).  Colors of arrowheads: white, normal expression; blue, 
downregulation (B-E).  The regional correlation between the domain where 
otx2 and p27xic1 are expressed.  Cross hemisections show the expression of 
otx2 (F) and p27xic1 (G) visualized by WISH, and mitotically active cells by 
the immunostaining of PH3 (H).  Lateral view with dorsal up, and anterior is 
left.  (F’,G’,H’) Enlarged image of F, G and H (gray dashed box).  White dashed 
lines indicate the position of the blastopore.  Scale bar, 500 μm (B-H); 250 μm 
(C’-H’).  (I) A schematic model of feedback loops involving Cdk, Otx2, and 
p27xic in cell-proliferation (left) and non-proliferation states (right).  Left, upon 
growth stimulation, (i) activation of Cdk causes phosphorylation of Otx2, (ii) 
phosphorylated Otx2 downregulates p27xic1, and (iii) the reduction of p27xic1 
increases Cdk activity, thereby enhancing both cell proliferation and a 
phosphorylation state of Otx2.  Right, upon the reduction of growth stimulation, 
(i) reduced Cdk activity causes the reduction of phosphorylation of Otx2, (ii) 
the reduction of phosphorylated Otx2 derepresses p27xic1, and (iii) increased 
p27xic1 inhibits Cdk activity, thereby reducing both cell proliferation and a 
phosphorylation state of Otx2.   
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Fig. 25. The repressor activity of Otx2 depends on its phosphorylation.  
(A-D) Repression of gbx2 by 4E.  mRNA (30 pg each) for globin (A), WT (B), 
4E (C), or 4A (D) was injected with nβ-gal mRNA into the animal pole region 
of a dorsal-right blastomere at the 4-cell stage.  Embryos were analysed by 
WISH at the late gastrula to early neurula stage (stages 12.5-13).  Dorsal view 
with anterior up. (A’,C’,D’) Enlarged images of A, C, and D (white dashed 
box).  MHB, the midbrain and hindbrain boundary.  (E-J) Activation of xcg1 by 
4E and 4A.  mRNA (30 pg each) for globin (E), WT (F), 4E (G), 4A (H), ΔAD-
4E (I), ΔAD-4A (J) was injected with nβ-gal mRNA.  Embryos were analysed 
by WISH at the late neurula stage (stages 18-20).  Anterior view with dorsal up.  
CG, cement gland.  Colors of arrowheads: white, normal expression; magenta, 
upregulation; blue, downregulation (A-J).  Scale bar, 500 μm (A-J); 250 μm 
(A’,C’,D’).  (K-N) Luciferase reporter assays.  (K-M) meis3-D2-luc reporter 
DNA was co-injected with mRNA for Otx2-WT, -4E or -4A (50 pg/embryo) (K) 
or with combinations of mRNAs for Gsc (12.5 pg/embryo), Tle1 (12.5 
pg/embryo), Otx2-WT and -4A (25 pg/embryo) as indicated (L,M).  (N) SOP-
FLASH reporter DNA construct was co-injected with mRNA for Otx2-WT, 4E 
or 4A (50 pg/embryo) (N).  *P<0.05, **P<0.01 (t-test); error bars, s.e.m.; n=5 
samples (K-N), NS, not significant (M).  (O) Physical interaction between Tle1 
and Otx2 mutant as assayed by Co-IP.  The amounts of expressed protein were 
verified by western blotting (lysate).  Magenta arrowheads, co-
immunoprecipitated bands; circles, heavy chains of IgG from the anti-Myc 
antibody.  
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Fig. 26については、5年以内に雑誌で刊行予定
のため、非公開。 
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Fig. 27. Regulatory principles by Otx2 phosphorylation in the anterior neural 
plate and retina.   
A schematic model of the regulatory mechanisms by Otx2 is shown.  See the 
text for explanation.   
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Fig. 28については、5年以内に雑誌で刊行予定
のため、非公開。 
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Fig. 29. Alignment of amino acid sequences of Xenopus Otx2, and Amphioxus 
Otx,  Sea urchin Otx and Sea anemone Otx. 
Xl_Otx2.L             ------------------------------------------------------------ 
Bf_Otx                ------------------------------------------------------------ 
Sp_Otx_isoform_a      MEALSDLASREIKMESHSPQDSKNLDVKPVKLERLGMSSSPPRLTIDCGDTGRSPVPSHM 60 
Sp_Otx_isoform_b      ------------------------------------MAYTIP------------PVP--- 9 
Nv_OtxA               ------------------------------------------------------------ 
Nv_OtxB               ------------------------------------------------------------ 
Nv_OtxC               ------------------------------------------------------------ 
                                                                                   
 
Xl_Otx2.L             ---------MMSYLKQPPYAVN-----GLSLTASG-------------MDLLHQSVG--- 30 
Bf_Otx                -----------MAYMKSPYGMNG-----LSLSNPSI-------------DLMTHHHHPGV 31 
Sp_Otx_isoform_a      EPPGGARVPYPMHLYPYPYAYSNPMYGEGALPAPDRHLPPTQQHPMFQPQVLGPMTSE-- 118 
Sp_Otx_isoform_b      -PQHHHHLQNKMNALGSPYSVN----GR-SLASPN-------------VELMHPAMS--- 47 
Nv_OtxA               ---------------MNSHAMG--------ITPPNI-------------DFFNHMVSP-- 22 
Nv_OtxB               --------MAGFLNNYPSYPMGS-----LNMPPRSS-------------EMFGPMVTP-- 32 
Nv_OtxC               --------MAGVFGRLPPYPMNG-----LNYPSPNF-------------DYYSPEAHG-- 32 
                                       .:  .         .  .              :           
 
Xl_Otx2.L             --------------YPA---TPRKQRRERTTFTRAQLDILEALFAKTRYPDIFMREEVAL 73 
Bf_Otx                GVSQYYNPTSAYTVTGQCPPPPRKQRRERTTFTRAQLDVLEALFAKTRYPDIFMREEVAL 91 
Sp_Otx_isoform_a      ------------RPHSNGVDPPRKQRRERTTFTRAQLDVLETLFSRTRYPDIFMREEVAM 166 
Sp_Otx_isoform_b      --------------YTN---PPRKQRRERTTFTRAQLDVLETLFSRTRYPDIFMREEVAM 90 
Nv_OtxA               ----------------SCSHPTRKQRRERTTFTKNQLEVLEELFAKTRYPDIFMREEVAI 66 
Nv_OtxB               ----------------PAFGYPRKQRRERTTFTKNQLEILEELFAKTRYPDIFMREEVAI 76 
Nv_OtxC               ----------------QMFGPPRKQRRERTTFTKNQLEILEELFAKTRYPDIFMREEVAI 76 
                                           .***********: **::** **::*************: 
 
Xl_Otx2.L             KINLPESRVQVWFKNRRAKCRQQQQQQQNGGQ-----NKVRPSKKKTSPVREVSSESGTS 128 
Bf_Otx                KINLPESRVQVWFKNRRAKCRQQAGQAK--PRPKKKSASPPPASTEEQAPTSESPSCSDS 149 
Sp_Otx_isoform_a      KINLPESRVQVWFKNRRAKCRQQQQQQQNGPNSNNTTNKPRPAKKKTPPPTPRENDAPTT 226 
Sp_Otx_isoform_b      KINLPESRVQVWFKNRRAKCRQQQQQQQNGPNSNNTTNKPRPAKKKTPPPTPRENDAPTT 150 
Nv_OtxA               KINLPESRVQVWFKNRRAKTRQLEKAAENKQKPERKPSTSTNSTPTTSAATPPTPLPPHP 126 
Nv_OtxB               KINLPESRVQVWFKNRRAKARQQAKGE---SKPKSKP-KSPSTSKEGSSLPPVLPPSPCR 132 
Nv_OtxC               KINLPESRVQVWFKNRRAKLRQLSKGQ---SKQSPKPVKRKSPSPEAEQHKPATPPQ-SH 132 
                      ******************* **         .      .   ..                 
 
Xl_Otx2.L             GQF-SPPS----STSVPVISSSTAP-VSIWSPAS----------------VSPL---SDP 163 
Bf_Otx                SVSSTPVPVAVSIGNNNASPTATVSTSSIWSPASAPSVTSDLGSCTSTVTSAPSCMQRSS 209 
Sp_Otx_isoform_a      TSSDTPP-----FKASPSVSSSMPNNNSIWSPAS----------------IAPQPMSSDH 265 
Sp_Otx_isoform_b      TSSDTPP-----FKASPSVSSSMPNNNSIWSPAS----------------IAPQPMSSDH 189 
Nv_OtxA               VAKDTSS------KSSPSPYDLPSCSGNLWNPVTS-----------------ANSPLPPA 163 
Nv_OtxB               YASCSGN---------------------IWSPAHE--PVRPS-TYSP------HSMMSTS 162 
Nv_OtxC               YVNSNPW------QQPPVDMRMPMGRS-NYQPPNM-----------------MNSMMGNM 168 
                                                   :.*                             
 
Xl_Otx2.L             LST---SSSCMQRSYPMTYTQ-ASGYS-QGYAGS----TSYFGGMDCGSYLSPMHHQLSG 214 
Bf_Otx                YNAYNHGGYTAHAQTYSPAPYPPTTYSATSYFGGMADCSSYLSP------MAPTHQLP-- 261 
Sp_Otx_isoform_a      LAANMSNNSCMQHSYTMPNAQPAAGYTAQGYQ------SPYFG---AG--LDYLSHMPQF 314 
Sp_Otx_isoform_b      LAANMSNNSCMQHSYTMPNAQPAAGYTAQGYQ------SPYFG---AG--LDYLSHMPQF 238 
Nv_OtxA               PNYGPPVLTNTSGPVFMPPPP----HTQSYRR-------QFTN-------PDCSYSIP-- 203 
Nv_OtxB               MTS-------SNAGAFMPPPQPPPYYCSSPSG-------PYMS-------MDHVHSMA-- 199 
Nv_OtxC               MNAG--CAIGSSGPRLLPPPPPSAYHHSSQEY-------PYMA-------NNPGQVPA-- 210 
                                       . .     :              :                    
 
Xl_Otx2.L             PGATLSPMGTNAVTS-HLNQSPVALSSQAYGASSLGFNSTDCLDYKDQTASWKLNFNADC--- 273 
Bf_Otx                PVTSLNQMSSANMSAHSMSHTPQLSPSSMGHGSPLNMSTQP-----------------DCVDY 307 
Sp_Otx_isoform_a      PGSINHQMAASAMNNGPMTTMASQLPPPHHAHMPMGAMSS-----------------AEC--- 357 
Sp_Otx_isoform_b      PGSINHQMAASAMNNGPMTTMASQLPPPHHAHMPMGAMSS-----------------AEC--- 281 
Nv_OtxA               SPYTMNRQMANPYNPTHM--------------------------------------------- 221 
Nv_OtxB               PR------------------------------------------------------------- 201 
Nv_OtxC               STIAGNPNIQGNFYTSSMM-------------------------------------------- 229 
                      .                                                            
 
Xl_Otx2.L             LDYKDQTSSWKFQVL 288 
Bf_Otx                TKHDQTSAWHKFQVL 322 
Sp_Otx_isoform_a      IDGKEQPQ-WKFQSL 371 
Sp_Otx_isoform_b      IDGKEQPQ-WKFQSL 295 
Nv_OtxA               --------------- 
Nv_OtxB               --------------- 
Nv_OtxC               --------------- 
                                      
  
T115 S116 
S132 S158 
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Abbreviations of species are Xenopus laevis (Xl), Branchiostoma belcheri (Bf), 
Strongylocentrotus purpuratus (Sp) and Nematostella vectensis (Nv).  Protein 
sequences were obtained from the NCBI database: Xl_Otx2.L (NP_001084955), 
Bf_Otx (XP_019625651), Sp_Otx isoform a (NP_999753), Sp_Otx isoform b 
(NP_001027540), Nv_OtxA (AFJ11251), Nv_OtxB (AFJ11250) and Nv_OtxC 
(AC053863).  Boxes coloured in green, homeodomain; blue, the conserved eh1 
repression motif of Otx; yellow, Otx tail motif.  Blue or magenta letters, consensus 
motifs for Akt and Cdks.  Bold cases, putative phosphorylation sites of Otx2 in Xenopus 
as shown in this study.   
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Fig. 1. Developmental processes of vertebrate eye.   
In the neurula embryo, the neural plate is divided into the presumptive 
forebrain-midbrain region and hindbrain region, respectively, in terms of the 
anteroposterior position.  As the first step of vertebrate eye development, the 
eye field, in which the eyes will be formed is specified in the center of the 
forebrain.  The eye field is gradually separated into two bilateral regions to give 
rise to the optic vesicles, and subsequently the optic cup and retina are formed.  
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Fig. 2. A model of  eye field formation in the anterior neural plate. 
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(A) Expression patterns of TFs otx2 (forebrain and midbrain, light blue), gbx2 
and meis3 (hindbrain, blue), rax and pax6 (eye field, magenta) in early Xenopus 
neurula embryos.  For the anteroposterior patterning in the neuroectoderm, otx2 
is expressed in the forebrain and midbrain, and gbx2 and meis3 are expressed in 
the hindbrain.  During late gastrulation, EFTF genes, rax and pax6, are 
expressed in the center of the region where otx2 is expressed.  (B) A schematic 
model of gene expression patterns of known EFTFs in early neurula (stages 12-
12.5, left) and mid-neurula (stage 15, right) embryos.  (C) A gene cascade of 
eye field specification.  In the early step of eye field specification, otx2 
upregulates the expression of rax and subsequently the expression of pax6 is 
activated, and otx2 represses the expression of tbx3.  During mid-step for eye 
field specification, rax in turn represses otx2, forming a negative feedback loop 
between otx2 and rax.  In addition, the expression of other EFTFs (six3, lhx2, 
six6, and tll) downstream of pax6 starts to be expressed.   
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Fig. 3〜Fig. 12については、5年以内に雑誌で
刊行予定のため、非公開。 
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Fig. 13. Expression patterns and gene interactions involved in the patterning of 
eye vesicle.   
(A) Expression patterns of otx2, pax6 and pax2 in the diencephalon, neural 
retina and optic stalk.  (B) A model for gene interactions for the establishment 
of the territories of eye vesicle.  The reciprocal repression of Otx2 and Pax2 
determines the segregation of RPE (the retinal pigment epithelium)/OS (optic 
stalk), and the similar mechanism is proposed for Pax2 and Pax6 interaction in 
the establishment of RPE/NR (neural retina).  It remains to be elucidated 
whether Otx2 contributes to the direct regulation of pax6.   
99 
B 
Cdk sites: S*/T*-P       
Akt sites: R/K-X2-S*/T* 
QQQQQQNGGQNKVRPSKKKTSPV
REVSSESGTSGQFSPPSSTSVPV
ISSSTAPVSIWSPASVSPLSDPL
STSSSCMQRSYPMTYTQASG  
96 
184 
115 116 
132 
158 
122 123 
153 161 
A 
FL (1-288) 
ΔAD ( 1-184) 
Myc-Otx2  AD HD 
RD 288 1 
E 
WT 3A 4A uninj. 
IP: anti-Myc 
WB: anti-
Phospho-Akt 
Substrate 
IP: anti-Myc 
WB: anti-Myc 
Myc-Otx2ΔAD constructs 
44 
44 
(kDa) 
1 2 3 4 
C 
S158A WT S132A S116A 
Myc-Otx2ΔAD constructs 
44 
(kDa) T115A S153A 
D 
44 
(kDa) 
Myc-Otx2  constructs  
λ-PP − − 
ΔAD ΔAD-3A 
− 
ΔAD-4A 
λ-PP λ-PP 
1 2 3 4 5 6 
Myc-Otx2  constructs  
λ-PP − − 
FL FL-3A 
λ-PP 
50 
57 
(kDa) 
− 
FL-4A 
λ-PP 
1 2 3 4 5 6 
100 
Fig. 14. Exogenous Otx2 is phosphorylated.   
(A) Schematic structures of Myc-Otx2 and deletion constructs.  The 
homeodomain (HD), repression domain (RD) and activation domain (AD) are 
indicated.  A Myc-tag at the N-terminus is indicated as a yellow box.  White 
star, Akt site; pink stars, Cdk sites.  The regions of Otx2 constructs are indicated 
by thick lines and positions of amino acid residues are indicated in parentheses.  
(B) Amino acid sequences around the repression domain.  Colored cases 
indicate the consensus motif for Cdks (magenta) and Akt kinase (blue).  Bold 
cases indicate modified serine and threonine residues that were suggested in the 
experimental process (T115, S116, S132 and S158).  Under line, the eh1 motif 
of the repression domain.  Consensus motifs for Cdk and Akt are indicated at 
the bottom.  *, phosphorylated serine/threonine residues.  (C) Western blotting 
of Myc-Otx2ΔAD constructs, WT and alanine mutants at T115 (T115A), S116 
(S116A), S132 (S132A), S153 (S153A) and S158 (S158A).  (D) Western 
blotting of Myc-Otx2ΔAD (upper) and Myc-Otx2FL constructs (lower), WT, 
3A and 4A with or without λ-protein phosphatase (λ-PP) treatment.  (E) IP-
western assay.  Myc-Otx2ΔAD was immunoprecipitated with anti-Myc 
antibody, and subjected to western blotting with the anti-Phospho-Akt substrate 
antibody (upper) or anti-Myc antibody (lower).  3A, alanine mutant at S116, 
S132 and S158; 4A, alanine mutant at T115, S116, S132 and S158; uninj., 
uninjected control; orange arrowheads, bands resistant to λ-PP.  FL, full length; 
WT, wild type; blue arrowheads, nascent proteins; magenta arrowheads, 
modified proteins.  Size markers (kDa) are indicated on the right of panels 
(C,D,E). 
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Xl_Otx2.L       MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDILEALFAK 59 
Xl_Otx5.L       MMSYIKQ-PHYAVNGLTLAGTGMDLLHSAVGYPTNPRKQRRERTTFTRAQLDILESLFAK 59 
Xt_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Xt_Otx5         MMSYIKQ-PHYAVNGLTLAGTGMDLLHSAVGYPTTPRKQRRERTTFTRAQLDILEALFAK 59 
Dr_Otx2         MMSYLKQ-PPYTVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Dr_Otx5         MMSYMKQ-PHYSVNGLTLTGTGMDLLHSAVGYPNTPRKQRRERTTFTRAQLDVLEALFSK 59 
Gg_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Gg_Otx5         MMSYIKQ-PHYAVNGLTLAGPGMDLLHSAVGYPATPRKQRRERTTFTRAQLDILEALFAK 59 
Mm_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Mm_Crx          MMAYMNPGPHYSVNALALSGPNVDLMHQAVPYSSAPRKQRRERTTFTRSQLEELEALFAK 60 
Hs_Otx2         MMSYLKQ-PPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAK 59 
Hs_Crx          MMAYMNPGPHYSVNALALSGPSVDLMHQAVPYPSAPRKQRRERTTFTRSQLEELEALFAK 60 
                **:*::  * *:**.*:*: ..:**:* :* *.  *************:**: **:**:*  
  
Xl_Otx2.L       TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPSKKK 114 
Xl_Otx5.L       TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQ--STGQAKPRPAKKK 112 
Xt_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPSKKK 114 
Xt_Otx5         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQ--STGQAKPRPAKKK 112 
Dr_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Dr_Otx5         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQ-TSGQTKPRPPKKK 113 
Gg_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Gg_Otx5         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQ--SSGQPKARPAKKK 112 
Mm_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Mm_Crx          TQYPDVYAREEVALKINLPESRVQVWFKNRRAKCRQQRQQQKQQQQPPGAQTKARPAKRK 120 
Hs_Otx2         TRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQ-----QQQQQQNGGQNKVRPAKKK 114 
Hs_Crx          TQYPDVYAREEVALKINLPESRVQVWFKNRRAKCRQQRQQQKQQQQPPGGQAKARPAKRK 120 
                *:***:: ****************************     :***    .* * **.*:*  
  
Xl_Otx2.L       T----SPAREVSSE---SGTSGQFSPPCS---TSGPVISSSTAPVSIWSPASISPLSDPL 164 
Xl_Otx5.L       T----SPARETNSE---ASTNGQYSPPPPG--TAVTPSSSASATVSIWSPASISPIPDPL 163 
Xt_Otx2         P----SPAREVSSE---SGTSGQFSPPCS---TSVPVISSSTAPVSIWSPASISPLSDPL 164 
Xt_Otx5         T----SPARETNSE---ASTNGQYSPPPPG--TAVTPSSTASATVSIWSPASISPIPDPL 163 
Dr_Otx2         S----SPAREASSE---SGASGQFTPPSS---TSVPAISTTTAPVSIWSPASISPLSDPL 164 
Dr_Otx5         S----SPARDSSASEPSASTSGPYSPPPPPPGTAITP-SSSSATVSIWSPASISPLPDPL 168 
Gg_Otx2         N----SPAREVSSE---SGTSGQFTPPSS---TSVPTISSSSAPVSIWSPASISPLSDPL 164 
Gg_Otx5         P----TPPREAPND---AGGAGPYSPTQP----GPAGTPGSAAPVSIWSPASISPVPDPL 161 
Mm_Otx2         S----SPAREVSSE---SGTSGQFSPPSS---TSVPTIASSSAPVSIWSPASISPLSDPL 164 
Mm_Crx          AGTSPRPSTDVCTDP--LGISDSYSPSLP---GPSGSPTTAVATVSIWSPASEAPLPEAQ 175 
Hs_Otx2         T----SPAREVSSE---SGTSGQFTPPSS---TSVPTIASSSAPVSIWSPASISPLSDPL 164 
Hs_Crx          AGTSPRPSTDVCPDP--LGISDSYSPPLP---GPSGSPTTAVATVSIWSPASESPLPEAQ 175 
                      *. :   .    .  . ::*. .         . : *.******** :*:.:.   
  
Xl_Otx2.L       S---TSSS-CMQRS---YPMTYTQASGYSQG---YASSTSYFGGMDCGSYLTPMHHQLSG 214 
Xl_Otx5.L       S---AVTNPCMQRST-GYPMTYSQAPAYTQS---YGGSSSYFTGLDCGSYLSPMHPQLSA 216 
Xt_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLSG 214 
Xt_Otx5         S---AATTPCMQRSA-GYPMTYSQAPAYTQS---YGGSSSYFTGLDCGSYLSPMHPQLSA 216 
Dr_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLTG 214 
Dr_Otx5         S---APSTACLQRSS--YPMTYSQAPAYGQS---YAASSSYFTGLDCSSYLSPMHPQLSA 220 
Gg_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLPG 214 
Gg_Otx5         A---AGSAPGLPRSAPFSAAPYNQTAPYGQS---YGGSAAYFGGLDCGAYLSPMHPPLGA 215 
Mm_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLPG 214 
Mm_Crx          RAGLVASGPSLTSAP--YAMTYAPASAFCSSPSAYASPSSYFSGLDP--YLSPMVPQLGG 231 
Hs_Otx2         S---TSSS-CMQRS---YPMTYTQASGYSQG---YAGSTSYFGGMDCGSYLTPMHHQLPG 214 
Hs_Crx          RAGLVASGPSLTSAP--YAMTYAPASAFCSSPSAYGSPSSYFSGLDP--YLSPMVPQLGG 231 
                    . :   :  :    . .*  :. : ..   *...::** *:*   **:**   * .  
  
Xl_Otx2.L       PGATLSPMSTNAVTSHLNQSQAALSSQAYGASSLGFNSTADCLDYKDQTASWKLNFNA-D 273 
Xl_Otx5.L       PGATLSPIATPTMGSHLSQSPASLSAQGYGAASLGFTS-VDCLDYKDQTASWKLNFNATD 275 
Xt_Otx2         AGATLSPMGTNAVTSHLNQSPAALSSQAYGASSLGFNSTADCLDYKDQTASWKLNFNA-D 273 
Xt_Otx5         PGATLSPIATPTMGSHLSQSPASLSAQGYGASSLGFTS-VDCLDYKDQTASWKLNFNATD 275 
Dr_Otx2         PGSTLSPMSSNAVTSHLNQSPASLPTQGYGASGLGFNSTADCLDYKDQASSWKLNFNA-D 273 
Dr_Otx5         SGGALSPMSG-----ALSQSPASLSSQGYTAASLGFGT-VDCLDYKDQTSAWKLNFNAAD 274 
Gg_Otx2         PGATLSPMGANAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNA-D 273 
Gg_Otx5         PGAALSPLGAP-MGAHLTPSPAALSGQSFGAG-LGFGA-VDCLEYKEQAGAWKLNFNAAD 272 
Mm_Otx2         PGATLSPMGTNAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNA-D 273 
Mm_Crx          P--ALSPLSGPSVGPSLAQSPTSLSGQSYSTYSP-----VDSLEFKDPTGTWKFTYNPMD 284 
Hs_Otx2         PGATLSPMGTNAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNA-D 273 
Hs_Crx          P--ALSPLSGPSVGPSLAQSPTSLSGQSYGAYSP-----VDSLEFKDPTGTWKFTYNPMD 284 
                .  :***:.       *  * ::*. *.: :        .*.*::*: :.:**:.:*. *  
  
Xl_Otx2.L       CLDYKDQTSSWKFQVL 289 
Xl_Otx5.L       CLDYKDQ-SSWKFQVL 290 
Xt_Otx2         CLDYKDQTSSWKFQVL 289 
Xt_Otx5         CLDYKDQ-SSWKFQVL 290 
Dr_Otx2         CLDYKDQTSSWKFQVL 289 
Dr_Otx5         CLDYKDQ-NSWKFQVL 289 
Gg_Otx2         CLDYKDQTSSWKFQVL 289 
Gg_Otx5         CLDYKEQ-SSWKFQVL 287 
Mm_Otx2         CLDYKDQTSSWKFQVL 289 
Mm_Crx          PLDYKDQ-SAWKFQIL 299 
Hs_Otx2         CLDYKDQTSSWKFQVL 289 
Hs_Crx          PLDYKDQ-SAWKFQIL 299 
                 ****:* .:****:*  
 Fig. 15. Alignment of amino acid sequences of Otx2 and Otx5/Crx among vertebrates. 
102 
Abbreviations of species are Xenopus laevis (Xl), Xenopus tropicalis (Xt), 
Danio rerio (Dr), Gallus gallus (Gg), Mus musculus (Mm) and Homo sapiens 
(Hs).  Protein sequences were obtained from the NCBI database: Xl_Otx2.L 
(NP_001084955), Xl_Otx5.L (NP_001081916), Xt_Otx2 (NP_001016177), 
Xt_Otx5 (NP_001016021), Dr_Otx2 (NP_571326), Dr_Otx5 (NP_851848), 
Gg_Otx2 (NP_989851), Gg_Otx5 (NP_001288716), Mm_Otx2 
(NP_001273412), Mm_Crx (NP_031796), Hs_Otx2 (NP_001257453), Hs_Crx 
(AAH53672).  Boxes coloured in green, homeodomain; blue, SIWSPAS motif; 
yellow, repeated Otx tail motif; red, Otx2 mutation sites (P133 and P134) that 
were reportedly associated with human ocular malformation.  Blue or magenta 
letters, consensus motifs for Akt and Cdks.  Bold cases, putative 
phosphorylation sites of Otx2 as shown in this study.   
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Fig. 16. The detection limit of Otx2FL and phosphorylation of endogenous Otx2 
by western blotting.  
(A) Embryos were injected with Otx2FL mRNA at various doses as indicated.  
Modified bands of Otx2FL was clearly detected when Otx2FL mRNAs were 
exogenously injected with greater than 400 pg per embryo, but not less than 200 
per embryo.  Embryonic lysate of 0.42 embryo equivalent was loaded per lane.  
(B) Western blotting of endogenous Otx2 (left panel) and exogenous Otx2FL 
construct (right panel) with or without λ-PP treatment.  Otx2FL and endogenous 
Otx2 was detected with anti-Otx2 antibodies (A,B).  Blue arrowheads, nascent 
proteins; magenta arrowheads, modified proteins.   
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Fig. 17. Effects of MAPK and Cdk on modifications of exogenous Otx2.   
(A) No effect of constitutively active mutant of MAPKK (MAPKK*) on 
modifications of Otx2.  Western blotting of Myc-Otx2ΔAD co-expressed with 
MAPKK*.  The amounts of injected MAPKK** mRNA were as indicated.  
mRNAs were injected into the animal pole region of both blastomeres at the 2-
cell stage.  (B) Phenotypes of Myc-Otx2ΔAD, HA-cyclin B1* (stable mutants 
of cyclin B1), and HA-cyclin A1* (stable mutants of cyclin A1) overexpressing 
embryos.  Embryos were observed at the early blastula stage (animal pole 
view).  (C,D) Western blotting of Myc-Otx2ΔAD co-expressed with HA-cyclin 
B1* (C) or HA-cyclin A1* (D).  Lysate were treated with λ-PP as indicated.  
Myc-Otx2ΔAD and HA-cyclin B1* or HA-cyclin A1* were detected with anti-
Myc and anti-HA antibodies, respectively.  Lysates were prepared from 
embryos at stage 8 (C) or stage 9 (D).  White asterisks, cell cycle-arrested 
blastomeres. Scale bars, 500 μm.  
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Fig. 18. Preference of cyclin B/Cdk and cyclin A/Cdks for Cdk sites of Otx2.   
(A) Schematic presentation of Myc-Otx2ΔAD with double (2A) and triple 
alanine (3A) mutations at S116, S132 and S158.  Yellow box, Myc-tag; black 
box, homeodomain (HD); blue box, repression domain (RD).  In the 2A 
constructs, for example, the S158 construct indicates mutations at S116 and 
S132.  S, serine phosphorylation sites (S116, S132, S158); A, alanine mutation.  
(B) Western blotting of Myc-Otx2ΔAD constructs (2A or 3A) co-expressed with 
(+) or without (-) HA-cyclin B1*.  (C) Western blotting of Myc-Otx2ΔAD 
constructs (2A or 3A) co-expressed with (+) or without (-) HA-cyclin A1*.  
Blue arrowheads, nascent bands; magenta arrowheads, modified bands; white 
arrowheads, additional modified bands at sites other than S116, S132 and S158.  
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Fig. 19. Effects of p27xic1 to phosphorylation of Otx2 and developmental 
changes of phosphorylation of Otx2. 
(A) Phenotype of p27xic1-overexpressing embryos (left) and western blotting of 
Myc-Otx2ΔAD co-expressed with p27xic1 (middle, right).  Co-injection 
(middle): Myc-Otx2ΔAD mRNA (500 pg/embryo) was coinjected with (lane 2) or 
without (lane 1) p27xic1 mRNA (2 ng/embryo) into one blastomere at the 2-cell 
stage.  Sequential injection (right): p27xic1 mRNA (1.5 ng/embryo) was injected 
into one blastomere at the 2-cell stage, then mRNAs for Myc-Otx2ΔAD (500 
pg/embryo) and p27xic1 (500 pg/embryo) were co-injected into the cleavage-
arrested blastomeres at the 32-cell stage equivalent (lane 4).  Myc-Otx2ΔAD 
mRNA was injected at the 2-cell stage as control (lane 3).  Lysates were prepared 
from embryos at stage 9 (lanes 1 and 2) or stage 9.5 (lanes 3 and 4).  White 
asterisks, cleavage-arrested blastomeres.  Scale bars, 500 μm.  (B) Developmental 
changes of phosphorylation of Otx2 as assayed by using Myc-Otx2ΔAD 
constructs. WT and alanine mutants of Otx2 in Myc-Otx2ΔAD constructs were 
analyzed from stages 5 to 10.5 as indicated.  TNT, in vitro translation products; 
blue arrowheads, nascent bands; magenta arrowheads, modified bands.   
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Fig. 20. Phosphomutants of Otx2 exhibit the distinct activity as assessed by 
developmental eye phenotype.  
(A-D) Eye phenotypes of Otx2 mutant-expressing embryos (stages 38-42).  
mRNA for Otx2 constructs were co-injected with nβ-gal mRNA as a tracer.  
Representative phenotypes in injected embryos (A-D): normal looking 
(normal), trace eye (trace), normal eye diameter with pigmentation defect at the 
ventral side (ventral defect) and enlarged retinal diameter with pigmentation 
defect at the ventral side (enlarged).  The white dashed lines indicate the 
diameter of the eye.  Anterior to the left, dorsal is up.  Scale bar, 500 μm.  (E) 
Activity of Otx2 mutants for eye malformation phenotypes.  The color bar (see 
panels A-D for color codes) indicates the percentages of the eye phenotype.  
Low-dose mRNA injection (20 pg/embryo) caused moderate phenotypes than 
high dose injection (40 pg/embryo).  n, total number of injected embryos.  (F) 
Quantitative assay for the ratio of the eye size in tailbud stage embryos (stages 
38-42).  **P<0.01 (t-test); error bars, s.e.m.; n=7 samples.  (G-H’) Transverse 
hemisection observations.  (G,G’) Globin injected control.  (H,H’) The enlarged 
eye phenotype of 4A-expressing embryo.  Bright field, G,H; DAPI staining, 
G’,H’.  Arrowheads, the retinal pigmentation defect at the ventral side.  Scale 
bar, 100 μm.   
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Fig. 21. Increased expression of eye marker genes by Otx2 mutant 4A.  
(A-T) mRNA for globin, WT, 4E or 4A (20 pg/embryo) was injected with nβ-
gal mRNA into the animal pole region of the dorsal-right blastomere at the 4-
cell stage, and embryos were subjected to WISH at early neurula stages (stages 
13-14) (A-H) and at late neurula stages (stages 18-20) (I-T).  MHB, the 
midbrain-hindbrain boundary; OS, optic stalk; OV, optic vesicle; Te, 
telencephalon, Di, diencephalon.  Arrowhead, the position of MHB; arrow, the 
expansion of pax6 expression to the anterior region.  Anterior view with dorsal 
up.  Scale bar, 500 μm.  (Q’-T’) Enlarged images of Q-T.  Black and white dash 
lines indicate diencephalon and optic vesicle regions, respectively, where pax6 
is expressed.  Scale bar, 100 μm.   
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Fig. 22. Phosphomimetic Otx2 mutant 4E stimulates cell proliferation. 
(A-C) mRNA for Otx2-WT (A), -4E (B) or -4A (C) together with that for eGFP 
as a tracer was injected in one blastomere at 2-cell stage.  4E and 4A are 
glutamate and alanine mutants, respectively, of full length Otx2 at T115, S116, 
S132 and S158.  Embryos were immunostained with anti-phospho-Histone H3 
(PH3) at the gastrula stage.  The dorsoanterior region was observed.  PH3-
positive nuclei were shown in red, Otx2 mutant-expressing cells (expressing 
eGFP) were shown in green.  White dash boxes in A-C correspond to enlarged 
area (A’-C”), respectively.  Scale bar, 200 μm.  (D) Quantitative assay for the 
ratio of PH3-positive nuclei.  (E-G) Representative images of DAPI-stained 
nuclei in Otx2-WT (E) or -4E (F) or -4A (G) expressing gastrula embryos.  The 
dorsoanterior region was observed.  Nuclei were shown in blue, Otx2 mutant-
expressing cells (expressing eGFP) were shown in green.  Red boxes in E, F and 
G correspond to enlarged area (E’-G”), respectively.  Scale bar, 200 μm (E-G); 
50 μm (E’-G”).  (H) Quantitative analysis for cell numbers.  More than 500 total 
nuclei were counted in one embryos, and 5 to 7 embryos were analysed for 
calculating the mean ratio (and s.e.m.) of the number of nuclei in injected 
versus uninjected areas.  **P<0.01 (t-test), *P<0.05 (t-test); error bars, s.e.m. 
(D,H).    
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Fig. 23. Reduction of cell proliferation by otx2/otx5 knockdown in Xenopus 
tropicalis embryos.   
Knockdown experiments were performed using Xenopus tropicalis.  (A,B) 
Effects of otx2/otx5-MO injection on mitotically active cells. White boxes, 
enlarged area (A’-B”).  (C) Quantitative analysis for the ratio of PH3-positive 
nuclei.  PH3-positive nuclei in an injected or uninjected area (0.072 mm2) in 
each embryo were counted (more than 60 nuclei in each area) with 9 embryos, 
and the ratio of the numbers of injected versus uninjected area was calculated 
for each embryo to obtain mean ± s.e.m. from 9 embryos.  The ratio of PH3-
positive nuclei in control MO-injected embryos was 1.15 ± 0.055 (mean ± 
s.e.m.), whereas that in otx2/otx5-MOs-injected embryos was 0.688±0.063, 
which significantly differed from the control (p = 4.95E-05).  (D,E) Effects of 
otx2/otx5-MO on cell density.  Red boxes, enlarged area (D’-E”).  (F) 
Quantitative analysis for the ratio of cell densities.  More than 500 total nuclei 
in each area (0.072 mm2) were counted in one embryo, and 9 embryos were 
analysed.  The ratio of cell density in control MO-injected embryos was 1.063 
± 0.034 (mean ± s.e.m.), whereas that in otx2/otx5-MOs-injected embryos 
was 0.906 ± 0.013, which differed from the control (p = 0.0015).  **P<0.01 (t-
test); error bars, s.e.m. (C,F).  Scale bar, 500 μm (A,B,D,E); 50 μm (A’-B”,D’-
E”,).  The amount of injected MO (pmol/embryo): control MO, 1; otx2/otx5, 0.5 
each.   
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Fig. 24. Phosphomimetic Otx2-4E mutant negatively regulates p27xic1 expression. 
(A) Genome browser representation showing occupancies of Otx2 and Tle1 in 
Xenopus tropicalis gastrula embryos for the p27xic1 gene.  (B-E) The WISH 
assay shows the expression of p27xic1 in Otx2 mutant-expressing embryos.  
mRNA (30 pg each) for globin (B), WT (C), 4E (D), or 4A (E) was injected 
with nβ-gal mRNA as a tracer into the animal pole region of the dorsal-left 
blastomere at the 4-cell stage.  The fractions indicate the proportion of the 
presented phenotype per total number.  Dorsal view with anterior up.  inj., 
injected side; uninj., uninjected side.  (C’,D’,E’) Enlarged image of C, D and E 
(white dashed box).  Colors of arrowheads: white, normal expression; blue, 
downregulation (B-E).  The regional correlation between the domain where 
otx2 and p27xic1 are expressed.  Cross hemisections show the expression of 
otx2 (F) and p27xic1 (G) visualized by WISH, and mitotically active cells by 
the immunostaining of PH3 (H).  Lateral view with dorsal up, and anterior is 
left.  (F’,G’,H’) Enlarged image of F, G and H (gray dashed box).  White dashed 
lines indicate the position of the blastopore.  Scale bar, 500 μm (B-H); 250 μm 
(C’-H’).  (I) A schematic model of feedback loops involving Cdk, Otx2, and 
p27xic in cell-proliferation (left) and non-proliferation states (right).  Left, upon 
growth stimulation, (i) activation of Cdk causes phosphorylation of Otx2, (ii) 
phosphorylated Otx2 downregulates p27xic1, and (iii) the reduction of p27xic1 
increases Cdk activity, thereby enhancing both cell proliferation and a 
phosphorylation state of Otx2.  Right, upon the reduction of growth stimulation, 
(i) reduced Cdk activity causes the reduction of phosphorylation of Otx2, (ii) 
the reduction of phosphorylated Otx2 derepresses p27xic1, and (iii) increased 
p27xic1 inhibits Cdk activity, thereby reducing both cell proliferation and a 
phosphorylation state of Otx2.   
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Fig. 25. The repressor activity of Otx2 depends on its phosphorylation.  
(A-D) Repression of gbx2 by 4E.  mRNA (30 pg each) for globin (A), WT (B), 
4E (C), or 4A (D) was injected with nβ-gal mRNA into the animal pole region 
of a dorsal-right blastomere at the 4-cell stage.  Embryos were analysed by 
WISH at the late gastrula to early neurula stage (stages 12.5-13).  Dorsal view 
with anterior up. (A’,C’,D’) Enlarged images of A, C, and D (white dashed 
box).  MHB, the midbrain and hindbrain boundary.  (E-J) Activation of xcg1 by 
4E and 4A.  mRNA (30 pg each) for globin (E), WT (F), 4E (G), 4A (H), ΔAD-
4E (I), ΔAD-4A (J) was injected with nβ-gal mRNA.  Embryos were analysed 
by WISH at the late neurula stage (stages 18-20).  Anterior view with dorsal up.  
CG, cement gland.  Colors of arrowheads: white, normal expression; magenta, 
upregulation; blue, downregulation (A-J).  Scale bar, 500 μm (A-J); 250 μm 
(A’,C’,D’).  (K-N) Luciferase reporter assays.  (K-M) meis3-D2-luc reporter 
DNA was co-injected with mRNA for Otx2-WT, -4E or -4A (50 pg/embryo) (K) 
or with combinations of mRNAs for Gsc (12.5 pg/embryo), Tle1 (12.5 
pg/embryo), Otx2-WT and -4A (25 pg/embryo) as indicated (L,M).  (N) SOP-
FLASH reporter DNA construct was co-injected with mRNA for Otx2-WT, 4E 
or 4A (50 pg/embryo) (N).  *P<0.05, **P<0.01 (t-test); error bars, s.e.m.; n=5 
samples (K-N), NS, not significant (M).  (O) Physical interaction between Tle1 
and Otx2 mutant as assayed by Co-IP.  The amounts of expressed protein were 
verified by western blotting (lysate).  Magenta arrowheads, co-
immunoprecipitated bands; circles, heavy chains of IgG from the anti-Myc 
antibody.  
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Fig. 26については、5年以内に雑誌で刊行予定
のため、非公開。 
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Fig. 27. Regulatory principles by Otx2 phosphorylation in the anterior neural 
plate and retina.   
A schematic model of the regulatory mechanisms by Otx2 is shown.  See the 
text for explanation.   
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Fig. 28については、5年以内に雑誌で刊行予定
のため、非公開。 
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Fig. 29. Alignment of amino acid sequences of Xenopus Otx2, and Amphioxus 
Otx,  Sea urchin Otx and Sea anemone Otx. 
Xl_Otx2.L             ------------------------------------------------------------ 
Bf_Otx                ------------------------------------------------------------ 
Sp_Otx_isoform_a      MEALSDLASREIKMESHSPQDSKNLDVKPVKLERLGMSSSPPRLTIDCGDTGRSPVPSHM 60 
Sp_Otx_isoform_b      ------------------------------------MAYTIP------------PVP--- 9 
Nv_OtxA               ------------------------------------------------------------ 
Nv_OtxB               ------------------------------------------------------------ 
Nv_OtxC               ------------------------------------------------------------ 
                                                                                   
 
Xl_Otx2.L             ---------MMSYLKQPPYAVN-----GLSLTASG-------------MDLLHQSVG--- 30 
Bf_Otx                -----------MAYMKSPYGMNG-----LSLSNPSI-------------DLMTHHHHPGV 31 
Sp_Otx_isoform_a      EPPGGARVPYPMHLYPYPYAYSNPMYGEGALPAPDRHLPPTQQHPMFQPQVLGPMTSE-- 118 
Sp_Otx_isoform_b      -PQHHHHLQNKMNALGSPYSVN----GR-SLASPN-------------VELMHPAMS--- 47 
Nv_OtxA               ---------------MNSHAMG--------ITPPNI-------------DFFNHMVSP-- 22 
Nv_OtxB               --------MAGFLNNYPSYPMGS-----LNMPPRSS-------------EMFGPMVTP-- 32 
Nv_OtxC               --------MAGVFGRLPPYPMNG-----LNYPSPNF-------------DYYSPEAHG-- 32 
                                       .:  .         .  .              :           
 
Xl_Otx2.L             --------------YPA---TPRKQRRERTTFTRAQLDILEALFAKTRYPDIFMREEVAL 73 
Bf_Otx                GVSQYYNPTSAYTVTGQCPPPPRKQRRERTTFTRAQLDVLEALFAKTRYPDIFMREEVAL 91 
Sp_Otx_isoform_a      ------------RPHSNGVDPPRKQRRERTTFTRAQLDVLETLFSRTRYPDIFMREEVAM 166 
Sp_Otx_isoform_b      --------------YTN---PPRKQRRERTTFTRAQLDVLETLFSRTRYPDIFMREEVAM 90 
Nv_OtxA               ----------------SCSHPTRKQRRERTTFTKNQLEVLEELFAKTRYPDIFMREEVAI 66 
Nv_OtxB               ----------------PAFGYPRKQRRERTTFTKNQLEILEELFAKTRYPDIFMREEVAI 76 
Nv_OtxC               ----------------QMFGPPRKQRRERTTFTKNQLEILEELFAKTRYPDIFMREEVAI 76 
                                           .***********: **::** **::*************: 
 
Xl_Otx2.L             KINLPESRVQVWFKNRRAKCRQQQQQQQNGGQ-----NKVRPSKKKTSPVREVSSESGTS 128 
Bf_Otx                KINLPESRVQVWFKNRRAKCRQQAGQAK--PRPKKKSASPPPASTEEQAPTSESPSCSDS 149 
Sp_Otx_isoform_a      KINLPESRVQVWFKNRRAKCRQQQQQQQNGPNSNNTTNKPRPAKKKTPPPTPRENDAPTT 226 
Sp_Otx_isoform_b      KINLPESRVQVWFKNRRAKCRQQQQQQQNGPNSNNTTNKPRPAKKKTPPPTPRENDAPTT 150 
Nv_OtxA               KINLPESRVQVWFKNRRAKTRQLEKAAENKQKPERKPSTSTNSTPTTSAATPPTPLPPHP 126 
Nv_OtxB               KINLPESRVQVWFKNRRAKARQQAKGE---SKPKSKP-KSPSTSKEGSSLPPVLPPSPCR 132 
Nv_OtxC               KINLPESRVQVWFKNRRAKLRQLSKGQ---SKQSPKPVKRKSPSPEAEQHKPATPPQ-SH 132 
                      ******************* **         .      .   ..                 
 
Xl_Otx2.L             GQF-SPPS----STSVPVISSSTAP-VSIWSPAS----------------VSPL---SDP 163 
Bf_Otx                SVSSTPVPVAVSIGNNNASPTATVSTSSIWSPASAPSVTSDLGSCTSTVTSAPSCMQRSS 209 
Sp_Otx_isoform_a      TSSDTPP-----FKASPSVSSSMPNNNSIWSPAS----------------IAPQPMSSDH 265 
Sp_Otx_isoform_b      TSSDTPP-----FKASPSVSSSMPNNNSIWSPAS----------------IAPQPMSSDH 189 
Nv_OtxA               VAKDTSS------KSSPSPYDLPSCSGNLWNPVTS-----------------ANSPLPPA 163 
Nv_OtxB               YASCSGN---------------------IWSPAHE--PVRPS-TYSP------HSMMSTS 162 
Nv_OtxC               YVNSNPW------QQPPVDMRMPMGRS-NYQPPNM-----------------MNSMMGNM 168 
                                                   :.*                             
 
Xl_Otx2.L             LST---SSSCMQRSYPMTYTQ-ASGYS-QGYAGS----TSYFGGMDCGSYLSPMHHQLSG 214 
Bf_Otx                YNAYNHGGYTAHAQTYSPAPYPPTTYSATSYFGGMADCSSYLSP------MAPTHQLP-- 261 
Sp_Otx_isoform_a      LAANMSNNSCMQHSYTMPNAQPAAGYTAQGYQ------SPYFG---AG--LDYLSHMPQF 314 
Sp_Otx_isoform_b      LAANMSNNSCMQHSYTMPNAQPAAGYTAQGYQ------SPYFG---AG--LDYLSHMPQF 238 
Nv_OtxA               PNYGPPVLTNTSGPVFMPPPP----HTQSYRR-------QFTN-------PDCSYSIP-- 203 
Nv_OtxB               MTS-------SNAGAFMPPPQPPPYYCSSPSG-------PYMS-------MDHVHSMA-- 199 
Nv_OtxC               MNAG--CAIGSSGPRLLPPPPPSAYHHSSQEY-------PYMA-------NNPGQVPA-- 210 
                                       . .     :              :                    
 
Xl_Otx2.L             PGATLSPMGTNAVTS-HLNQSPVALSSQAYGASSLGFNSTDCLDYKDQTASWKLNFNADC--- 273 
Bf_Otx                PVTSLNQMSSANMSAHSMSHTPQLSPSSMGHGSPLNMSTQP-----------------DCVDY 307 
Sp_Otx_isoform_a      PGSINHQMAASAMNNGPMTTMASQLPPPHHAHMPMGAMSS-----------------AEC--- 357 
Sp_Otx_isoform_b      PGSINHQMAASAMNNGPMTTMASQLPPPHHAHMPMGAMSS-----------------AEC--- 281 
Nv_OtxA               SPYTMNRQMANPYNPTHM--------------------------------------------- 221 
Nv_OtxB               PR------------------------------------------------------------- 201 
Nv_OtxC               STIAGNPNIQGNFYTSSMM-------------------------------------------- 229 
                      .                                                            
 
Xl_Otx2.L             LDYKDQTSSWKFQVL 288 
Bf_Otx                TKHDQTSAWHKFQVL 322 
Sp_Otx_isoform_a      IDGKEQPQ-WKFQSL 371 
Sp_Otx_isoform_b      IDGKEQPQ-WKFQSL 295 
Nv_OtxA               --------------- 
Nv_OtxB               --------------- 
Nv_OtxC               --------------- 
                                      
  
T115 S116 
S132 S158 
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Abbreviations of species are Xenopus laevis (Xl), Branchiostoma belcheri (Bf), 
Strongylocentrotus purpuratus (Sp) and Nematostella vectensis (Nv).  Protein 
sequences were obtained from the NCBI database: Xl_Otx2.L (NP_001084955), 
Bf_Otx (XP_019625651), Sp_Otx isoform a (NP_999753), Sp_Otx isoform b 
(NP_001027540), Nv_OtxA (AFJ11251), Nv_OtxB (AFJ11250) and Nv_OtxC 
(AC053863).  Boxes coloured in green, homeodomain; blue, the conserved eh1 
repression motif of Otx; yellow, Otx tail motif.  Blue or magenta letters, consensus 
motifs for Akt and Cdks.  Bold cases, putative phosphorylation sites of Otx2 in Xenopus 
as shown in this study.   
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